Obama will Stammzellenforschung lockern - Schubkraft für CBAI - 500 Beiträge pro Seite

[ollinbg]

Hohes Volumen!

Cord Blood America Salutes President-Elect Obama\'s Promise to Lift Restrictions on Stem Cell Research


SANTA MONICA, Calif., Nov. 11 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC:CBAI) (BULLETIN BOARD: CBAI) , the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com/)" target="_blank" rel="nofollow ugc noopener">http://www.cordblood-america.com/) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that the stem cell industry is surging with the news that President-elect Barack Obama intends to use his executive authority to reverse current policies barring certain stem cell research funded by the Federal government.

Administration officials, including John Podesta, who is heading up the transition team for the nation\'s next President, have told the media that President-elect Obama will reverse the nation\'s policies on stem cell research as soon as he takes office in January 2009.

\"News of increased stem cell research is welcome and has caused a huge increase in interest on Wall Street and elsewhere in stem cell companies,\" said Matthew Schissler, founder and CEO. \"The movement in the markets solidifies that Wall Street is placing a value on stem cell initiatives by the new administration, and moreover, we believe those values will ultimately reflect in stem cell revenue-generating companies like CBAI.\"

\"We are delighted by this interest because we know what role stem cells can play in solving some of our most intractable health care issues, including cancer, diabetes and heart disease,\" said Mr. Schissler.

Mr. Schissler plans to post a shareholder letter later this month detailing the benefits stem cell therapies going to market and how these game changing events will positively impact the growth of CBAI\'s stem cell storage services.

About Cord Blood America

Cord Blood America (OTC:CBAI) (BULLETIN BOARD: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC:CBAI) (BULLETIN BOARD: CBAI) , visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/." target="_blank" rel="nofollow ugc noopener">http://www.cordblood-america.com/.

CONTACT: Paul Knopick E & E Communications 949/707-5365

DATASOURCE: Cord Blood America, Inc.


CONTACT: Paul Knopick of E & E Communications, [phone],

, for Cord Blood America, Inc.


Web site: http://www.cordblood-america.com/

[ollinbg]

Antwort auf Beitrag Nr.: 35.913.156 von ollinbg am 11.11.08 17:29:48

Hält sich wacker - bin auf die letzte Stunde gespannt!

[ollinbg]

[ollinbg]

Noch jemand mit dabei?

[Csillagok]

Antwort auf Beitrag Nr.: 35.915.262 von ollinbg am 11.11.08 20:32:27

Nöööööööööööööööööööööööööööö ...........


Naja, auf die "watchlist" kann man die ja mal setzen.
Kost ja nix.
Schau mer mal ....

[Sugar2000]

naja, ob man langfristig mit einem OTC Wert gewinnt, lasse ich mal dahingestellt.
Ich persönlich finde Werte wie Geron, Stemcells und Aastrom wesentlich interessanter!!!!

[ollinbg]

Antwort auf Beitrag Nr.: 35.917.460 von Sugar2000 am 11.11.08 23:45:07

Guten morgen

Sehe das auch nicht als langfristiges Investment.
Wenn man mal ein paar Charts anschaut, schaut das eher nach einem Run aus. Die große Aufmerksamkeit für den Wert kommt erst langsam. Wenn dann hier mal richtig Volumen rein kommt, gehts richtig ab.

Zumal die Marktkapitalisierung aktuell nur so 1,5Mio Dollar betragen sollte!
Bei laut Ihub 5Mio Umsatz im Jahr.

Könnte ein schöner Zock werden!

[ollinbg]

Hier die letzte News:

Cord Blood America Celebrates Sixth Anniversary; Has Grown to One of the Largest Stem Cell Companies in Its Sector
- Continued National, International Growth Predicted -
SANTA MONICA, Calif., Sept. 18 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, now celebrating the sixth anniversary of its founding, said today it has grown from 16th largest company in the sector to fourth largest in the United States during this period.

'Strategic organic growth, combined with three accretive acquisitions, has allowed Cord Blood America to grow into the top tier of companies providing this important service,' said Matthew Schissler, founder and CEO. 'We bought Cryobank for Oncologic and Reproductive Donors, Inc., in New York, in January 2006, CorCell, a much larger company than ours, headquartered in Philadelphia, in October 2006, and CureSource in South Carolina in August 2007, thereby fueling our growth.'

Mr. Schissler said the Company has become much 'smarter' in its operations over this time period, improving margins from 34 to 51 percent within the last 12 months. 'Our strategy for the next six years is to be very prudent, but also very aggressive, with continued acquisitions both domestically and internationally. We are in the midst of due diligence on several very interesting potential deals.'

'The strategy is in place to grow Cord Blood America out of the number four spot to go higher in the sector,' the Company's founder said. 'We are especially interested in expanding the North American market through our health insurance partnership model, while vigorously investigating the international market, where the saving of umbilical cord blood stem cells is just beginning to be understood as a wise, safe, and sound insurance policy for the child.' Cord Blood America already has a subsidiary in Greece, which has announced it is examining expansion in Europe, including in Germany.

'This is a very dynamic industry. Our first six years have not been without its share of challenges but we have learned a tremendous amount and our growth has provided us a solid foundation for which we intend the next six years to be even more successful,' Mr. Schissler said.

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at http://www.corcell.com. For investor information, visit http://www.cordblood-america.com.

CONTACT:
Paul Knopick
E & E Communications
949/707-5365
[e-mail]

SOURCE Cord Blood America, Inc.



Source: PR Newswire (September 18, 2008 - 4:00 AM EDT)

News by QuoteMedia

[Sugar2000]

Antwort auf Beitrag Nr.: 35.919.969 von ollinbg am 12.11.08 08:05:39

Umsatz 4 Mio USD, allerdings Verlust von über 6 Mio USD!!!

Aber das kann unter charttechnischen und psychologischen Gesichtspunkten egal sein!
Jedoch ist sowas nichts für mich!
Viel Erfolg!

[ollinbg]

Antwort auf Beitrag Nr.: 35.920.409 von Sugar2000 am 12.11.08 08:49:39

Stimmt, fundamental darf man die meisten Buden hier nicht betrachten. Aber wenigstens haben die schonmal Umsätze und sind nicht ein reines Luftschloss.

Mal schauen, wie heute die Stimmung da drüben ist.

[ollinbg]

gleich gehts los...
aktuell
005 x 0075

[Csillagok]

Antwort auf Beitrag Nr.: 35.925.677 von ollinbg am 12.11.08 15:29:29

Nichts geht los !

[ollinbg]

CORD BLOOD AMERICA INC (U-CBAI) - News Release

Cord Blood America Posts Letter to Shareholders: New Administration's Potential Enhanced Stem Cell Research Initiative Should Benefit the Company and Its Shareholders

2008-11-13 09:00 ET - News Release

SANTA MONICA, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that a letter to shareholders from CEO Matthew Schissler has been posted on the Company's website. The letter explains some of the positive scientific and economic implications of the potential enhanced stem cell research initiatives proposed by the new Obama Administration.

On Sunday, November 9, 2008, John Podesta, who is leading President Elect Barack Obama's transition team, told Fox News (http://www.foxnews.com/story/0,2933,449164,00.html):

"We're looking at -- again, in virtually every agency to see where we can move forward, whether that's on energy transformation, on improving health care, on stem cell research.

There's a lot that the president can do using his executive authority without waiting for congressional action, and I think we'll see the president do that ..."

Mr. Schissler commented, "Because of this interview, there seems to be a rejuvenated and heightened awareness to stem cells and the philosophy change that is anticipated from our President Elect. It is my hope that, through a series of communicative letters to shareholders and families alike, that CBAI can provide valuable information from both a macroeconomic perspective, as well as a direct relation to the individual."

"I am often asked the question: 'What does this mean for Cord Blood America?'" Mr. Schissler said. "Families ask us: 'What does this mean for my family, should I store stem cells, what are the differences between embryonic and adult stem cells, and what does the research mean to our medical community and our economy?'"

"We believe the letter that was posted today and which can be accessed at http://www.cordblood-america.com will help answer some of these questions," Cord Blood America's CEO said. "In summary, we believe that an infusion of capital into stem cell research and development will lead to more therapies being commercialized, a higher percentage of families benefiting from these therapies and, subsequently, a higher percentage of families choosing to store stem cells. We believe this is a significant positive for both stem cell companies and our shareholders."

About Cord Blood America

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. , visit our website at http://www.corcell.com. For investor information, visit http://www.cordblood-america.com.

Forward-Looking Statements

Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company's performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

CONTACT:
Paul Knopick
E & E Communications
949/707-5365
[e-mail]

Cord Blood America, Inc.

CONTACT: Paul Knopick of E & E Communications, [phone],
[e-mail], for Cord Blood America, Inc.

Web site: http://www.cordblood-america.com/
http://www.corcell.com/

[Csillagok]

Antwort auf Beitrag Nr.: 35.938.828 von ollinbg am 13.11.08 15:37:54

gäääääääääääääähn ....

[ollinbg]

Antwort auf Beitrag Nr.: 35.940.254 von Csillagok am 13.11.08 18:01:58

Keiner wird gezwungen das hier zu lesen

[egon-olsen]

tote Hose

[ollinbg]

Gestern Ausbruch über die 0.003.
Viel Beachtung in den Amerikanischen Boards für die CBAI.
Im Zuge der StemCell-Plays (vgl ACTC) könnte es hier noch gut weitergehen!

[ollinbg]

positiver cashflow im 3. Quartal 2009 erwartet!

Interessante Investor Präsentation aus dem Filing vom 30.12.2008 ist hier zu sehen:
http://www.slideshare.net/netgenpr/cbai-investor-presentatio…

[beatback]

Hier mal der RT Chart:




Viel Erfolg allen Investierten!

[beatback]

sorry, falscher Chart, hier der richtige:

[papschy]

Antwort auf Beitrag Nr.: 36.356.286 von beatback am 12.01.09 16:12:08

So und jetzt schnell über 0.005 $

[papschy]

Gleich ist es soweit , dann ist die 0,005 Vergangenheit .

[nellocat]

Antwort auf Beitrag Nr.: 36.357.871 von papschy am 12.01.09 18:48:28

knapp 25 mio gehören mir jetzt

[papschy]

Antwort auf Beitrag Nr.: 36.360.662 von nellocat am 13.01.09 09:07:44

Du möchtest mir sagen das Du mit 130.000 €
in einen otc Wert investiert bist , ich lach mich schlapp .

Gruß Papschy

P.S. Ich habe 400.000 und finde das reicht .

[papschy]

So gleich ist die 0,006 auch Geschichte

[kardoss12]

ich würde lieber sehr vorsichtig investieren !

[papschy]

Antwort auf Beitrag Nr.: 36.365.153 von kardoss12 am 13.01.09 17:27:04

Dann such Dir einen Dax Wert Hier braucht Mann Eier

[SGDfigther]

Antwort auf Beitrag Nr.: 36.360.662 von nellocat am 13.01.09 09:07:44

Wer soll die dir abkaufen.

[gerdass]

Antwort auf Beitrag Nr.: 36.360.662 von nellocat am 13.01.09 09:07:44

Die nicht sehen und doch glauben
Ich mache hier auch mit.

[gerdass]

Antwort auf Beitrag Nr.: 36.367.240 von SGDfigther am 13.01.09 21:23:06

Schau dir mal den heutigen Handelsverlauf an.

[gerdass]

Ich bewundere diese Ruhe hier.
Einfach zu genial.

[AmbientA]

!

Dieser Beitrag wurde moderiert. Grund: Spammposting

[talis]

Antwort auf Beitrag Nr.: 36.470.607 von AmbientA am 29.01.09 02:13:26

den Schwachsinn über die Firma, die nur noch Flugzeugteile verkaufen will postet dieser anonyme Schreiber in jedem thread

[spekulativ]

Antwort auf Beitrag Nr.: 36.469.444 von gerdass am 28.01.09 21:16:23

ist ab und zu halt so.

lg speku

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.474.600 von spekulativ am 29.01.09 16:04:04

[KlausStoertebeker]

....geiler Chart

[spekulativ]

Antwort auf Beitrag Nr.: 36.474.858 von KlausStoertebeker am 29.01.09 16:30:30

so bis später mein bester

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.474.874 von spekulativ am 29.01.09 16:32:32

[beatback]

Meint Ihr, man kann da noch einsteigen?

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.475.047 von beatback am 29.01.09 16:50:53

....wann und wo ?

[KlausStoertebeker]

0,018 ist das geil

[KlausStoertebeker]

...sorry 0,020

[KlausStoertebeker]

...fette Kaufblöcke

[KlausStoertebeker]

...wo endet das nur ....

[KlausStoertebeker]

..Volumen...100M ..und drüber

[KlausStoertebeker]

0,022...und Käufer ohne ende ....

[gerdass]

[jub2]

ach menno... kurz mal weg und noch gegrübelt ob ich einsteigen soll und jetzt komm ich wieder an meinen Rechner ran und nun das hier.

Boooom...

sauber den einstieg verpasst... wie lang trägt die welle hier noch? Hat ihr ein Gefühl dafür?

[jub2]

Antwort auf Beitrag Nr.: 36.475.441 von jub2 am 29.01.09 17:40:14

halt wo laufen Sie denn??? ja wo lauen Sie denn????

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.475.441 von jub2 am 29.01.09 17:40:14

Nein...scheint aber kein Zock zu sein !

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.475.441 von jub2 am 29.01.09 17:40:14

....scheint noch kein ende in sicht ....

[jub2]

Antwort auf Beitrag Nr.: 36.475.462 von KlausStoertebeker am 29.01.09 17:42:31

uh, mit ner vorsicht position noch rein... und gezittert und jetzt der turbo??? was ist denn da los?

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.475.489 von jub2 am 29.01.09 17:45:32

....mag sein an dem

Cord Blood America, Inc. (OTCBB: CBAI - http://finance.yahoo.com/q?s=CBAI.OB ) (Tue, Jan 27, 2009, 9:35 am EST) Cord Blood America, Inc., the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that it intends a rapid expansion of its health insurance partnership program to new geographies in 2009. This announcement from Cord Blood America comes on the heels of last week's announcement that the Food and Drug Administration and the U.S. government will allow the world's first test in people of a therapy derived from human embryonic stem cells. For more information, see the social media news room at http://www.intelligendo.com.

Founder and CEO Matthew Schissler, in reviewing the domestic stem cell industry, predicts that 2009 will be an excellent, milestone year for stem cell storage companies, including CBAI. "Now is the right time. We have focused our business on three primary locations for several years, developing deep relationships with health insurance providers to become their recommended source for storage of umbilical cord blood stem cells."

Mr. Schissler says Cord Blood America's stem cell storage subsidiary, CorCell, will attempt to enter into contracts with two or three more geographic health insurance providers, which would double the company's current health insurance provider base.

"With a national health insurance plan and stem cell agenda as two of the primary topics from the new administration, we see a marriage of the insurance companies possibly paying for stem cell storage on the horizon, even if it is on a limited basis for high risk families. By developing the insurance sales channel, we feel we are positioning ourselves for long term success in becoming a globally dominant stem cell storage company."

Mr. Schissler went on to say that the growth will have limited cost because all infrastructure needed has been put into place over the course of many years.

CBAI has a history of being able to finance its growth, with the most recent funding of $4 million transacting in July of 2008. "With a very low cash burn, we feel we're well financed for the next few years," Schissler commented. "We'll use this time to get cash flow positive and reduce debt while growing both organically and through accretive acquisitions."

The company also is reporting tremendous success in engaging its clients, prospective clients, shareholders and prospective investors via social media with the help and intuition of NetGenPR (www.netgenpr.com). Cord Blood America is currently on Twitter, Facebook and Intelligendo, and soon to be available on FriendFeed. Cord Blood America's address on Twitter is http://www.twitter.com/cbai. "The conversation has begun. Groups from all over are discussing the impact of stem cells on every day life. We're glad we can lead and moderate this information, while trying to be a stem cell company of the people."

As previously reported, from 2003 to 2007, CBAI focused on growth. In 2008, the Company changed its tactics attempting to de-lever the company while becoming purely a stem cell storage company, and in the process de-emphasizing its non-core family advertising business.

As such, Cord Blood America has reported through first nine months:

-- Gross profits for the first nine months have increased to $1.8 million, a 54 percent margin, compared to a 42 percent margin in 2007.

[KlausStoertebeker]

Cord Blood America Inc. (OTCBB: CBAI | Quote | Chart | News | PowerRating) through its subsidiaries, provides private cord blood stem cell preservation services to families in the Untied States. The company also engages in the collection, testing, processing, and preservation of peripheral blood and adipose tissue stem cells, which allows individuals to privately preserve their stem cells for potential future use in stem cell therapy. In addition, it engages in the collection, transportation, testing, and preservation of umbilical cord blood. Further, the company engages in the advertising operations, including procuring and placing radio and television advertising; per-inquiry advertising on radio and television; producing radio and television commercials; procuring and setting up call centers; editing, dubbing, and distributing radio and television commercials; procuring and placing advertising sponsorships in motor sports; procuring and creating telephone on-hold advertising messages; and procuring and placing print advertising. The company, formerly known as D & A Lending, Inc., was founded in 2003. Cord Blood America is headquartered in Santa Monica, California. With 277.26 million shares outstanding and 80,100 shares declared short as of October 2008, there is no longer a failure to deliver in shares of CBAI. According to quarterly data provided by the SEC, there were still 4,342,860 shares of CBAI that were failing-to-deliver as of September 18, 2007.

[KlausStoertebeker]

...der Chart sieht wie gewollt aus...immer kurze Rücksetzer und dann wieder schön nach oben..wenn das so weitergeht ...fällt heute noch die 0,03

[jub2]

Antwort auf Beitrag Nr.: 36.475.654 von KlausStoertebeker am 29.01.09 18:04:16

der große Block macht den Nachtisch jetzt aber sauer...

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.475.755 von jub2 am 29.01.09 18:16:17

....ist gerade mittag drüben...mal sehen ...was wird

[spekulativ]

alles im grünen bereich

wird gerade luft geholt



imho speku

[spekulativ]

Antwort auf Beitrag Nr.: 36.475.950 von spekulativ am 29.01.09 18:39:57

mittag vorbei wie man erkennen kann

[spekulativ]

und immer noch grün

[KlausStoertebeker]

und grün geschlossen

[KlausStoertebeker]

http://www.pinksheets.com/pink/quote/quote.jsp?symbol=cbai

[KlausStoertebeker]

...könnte dem ganzen zum Wochenende noch einen schönen Schub geben...

[KlausStoertebeker]

MoneyTV, Week of 1/30

LOS ANGELES, CA, Jan 30, 2009 (MARKET WIRE via COMTEX) -- MoneyTV is the nationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews by anchor Donald Baillargeon with company CEOs, providing insights into their operations and outlooks for their futures.
Free information packages from the featured companies can be requested by sending an email to [e-mail].

The television program can also be viewed online immediately at www.moneytv.net.

Featured companies on this week's program include:

Carbon Sciences, Inc. (OTCBB: CABN) Newly appointed President & COO Byron Elton spoke of the science of turning CO2 into fuels.

The Green Baron Report Editor in Chief Matt Chipman analyzed the markets in the current economic turmoil.

Cord Blood America, Inc. (OTCBB: CBAI) CEO Matthew Schissler spoke of the company's recent spike in trading volume.

OriginOil, Inc. (OTCBB: OOIL) CEO Riggs Eckelberry outlined his vision for fuel created from algae.

Platinum Studios, Inc. (OTCBB: PDOS) talked about projects heading towards production and successful funding efforts.

Itronics, Inc. announced increases in sales during 2008.

Viewers of MoneyTV can receive free information in the mail about featured companies by calling the toll-free phone number on their TV screen. The weekly television program debuted in 1996 and is broadcast nationally in the USA to 70 million U.S. homes on Saturdays at 11:00 AM ET, Sundays at 8:30 AM PT, 8:30 AM ET, 9:30 AM ET, 3:30 PM ET and Mondays at 6:30 PM ET.

MoneyTV is broadcast to 45 million TV homes in Western Europe, Wednesdays at 5:00 PM, on UPN-TV in the Virgin Islands and Puerto Rico Sundays at 8:00 AM and is also available in Thailand on the Broad TV Network. The program airs eight times per week in the 21 Caribbean Territories on CaribVision Network.

A complete menu of TV listings is available at the MoneyTV web site, http://www.moneytv.net

MoneyTV Executive Producer and Anchor Don Baillargeon is also the host of MoneyRap Radio, http://www.moneyrap.com and Health This Week, http://www.healththisweek.com.

MoneyTV television program, Copyright MMIX all rights reserved. MoneyTV does not provide an analysis of companies' financial positions and is not soliciting to purchase or sell securities of the companies, nor are we offering a recommendation of featured companies or their stocks. Information discussed herein has been provided by the companies and should be verified independently with the companies and a securities analyst. MoneyTV provides companies a 3 to 4 month corporate profile with multiple appearances for a cash fee of $11,500.00 to $17,250.00, does not accept company stock as payment for services, does not hold any positions, options or warrants in featured companies. The information herein is not an endorsement by Donald Baillargeon, the producers, publisher or parent company of MoneyTV.



Contact:
Donald Baillargeon
Executive Producer

[KlausStoertebeker]

...was meint Ihr ?

[KlausStoertebeker]

http://www.pinksheets.com/pink/quote/quote.jsp?symbol=cbai

[KlausStoertebeker]

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders.

CBAI News:

January 27 - With the Embryonic Stem Cell Trial Cleared by the FDA as a Key Indicator, Cord Blood America Announces Expansion Plans for Its Stem Cell Storage Program

More Stem Cell Agenda News Expected From the Obama Administration This Week

Cord Blood America, Inc. (OTCBB: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, said that it intends a rapid expansion of its health insurance partnership program to new geographies in 2009. This announcement from Cord Blood America comes on the heels of last week's announcement that the Food and Drug Administration and the U.S. government will allow the world's first test in people of a therapy derived from human embryonic stem cells. For more information, see the social media news room at www.intelligendo.com.

Founder and CEO Matthew Schissler, in reviewing the domestic stem cell industry, predicts that 2009 will be an excellent, milestone year for stem cell storage companies, including CBAI. "Now is the right time. We have focused our business on three primary locations for several years, developing deep relationships with health insurance providers to become their recommended source for storage of umbilical cord blood stem cells."

Mr. Schissler says Cord Blood America's stem cell storage subsidiary, CorCell, will attempt to enter into contracts with two or three more geographic health insurance providers, which would double the company's current health insurance provider base.

"With a national health insurance plan and stem cell agenda as two of the primary topics from the new administration, we see a marriage of the insurance companies possibly paying for stem cell storage on the horizon, even if it is on a limited basis for high risk families. By developing the insurance sales channel, we feel we are positioning ourselves for long term success in becoming a globally dominant stem cell storage company."

Mr. Schissler went on to say that the growth will have limited cost because all infrastructure needed has been put into place over the course of many years.

CBAI has a history of being able to finance its growth, with the most recent funding of $4 million transacting in July of 2008. "With a very low cash burn, we feel we're well financed for the next few years," Schissler commented. "We'll use this time to get cash flow positive and reduce debt while growing both organically and through accretive acquisitions."

The company also is reporting tremendous success in engaging its clients, prospective clients, shareholders and prospective investors via social media with the help and intuition of NetGenPR (www.netgenpr.com). Cord Blood America is currently on Twitter, Facebook and Intelligendo, and soon to be available on FriendFeed. Cord Blood America's address on Twitter is www.twitter.com/cbai. "The conversation has begun. Groups from all over are discussing the impact of stem cells on every day life. We're glad we can lead and moderate this information, while trying to be a stem cell company of the people."

As previously reported, from 2003 to 2007, CBAI focused on growth. In 2008, the Company changed its tactics attempting to de-lever the company while becoming purely a stem cell storage company, and in the process de-emphasizing its non-core family advertising business.

As such, Cord Blood America has reported through first nine months:

* Gross profits for the first nine months have increased to $1.8 million, a 54 percent margin, compared to a 42 percent margin in 2007.

* SGA is down nearly $900,000, a 23 percent savings.

* Loss from operations is down nearly 20 percent.

* Loss per share is down 60 percent, from 0.05 to 0.02.

"We believe 2009 to be a turning point year for CBAI. We're excited to get going," Mr. Schissler concluded.

ANGIOTECH PHARMACEUTICALS INCORPORATED (NASDAQ: ANPI) "Up 18.06% on Thursday"

[KlausStoertebeker]

http://www.cordblood-america.com/
...mal zum warm werden

[KlausStoertebeker]

OTCPicks.com: OTCPicks.com Stocks to Watch for Friday, January 30th PSTI, CBAI, ANPI, ISSC
Fri. January 30, 2009; Posted: 04:38 AM
Free Trading Education with Larry Connors
Jan 30, 2009 (M2 PRESSWIRE via COMTEX) -- PSTI | Quote | Chart | News | PowerRating -- Our Stocks to Watch tomorrow include Pluristem Therapeutics Inc. (Nasdaq: PSTI), Cord Blood America Inc. (OTCBB: CBAI), Angiotech Pharmaceuticals Inc. (Nasdaq: ANPI | Quote | Chart | News | PowerRating) and Innovative Solutions & Support Inc. (Nasdaq: ISSC).

http://www.tradingmarkets.com/.site/news/Stock%20News/215102…

[KlausStoertebeker]

Auch sehr interessant.....


StockProfiler.US: Cashing In With President Obama: Stem Cell Research & Energy Efficiency News
Thu. January 29, 2009; Posted: 01:16 PM
Spring Trading with Larry Connors
New York, NY, Jan 29, 2009 (M2 PRESSWIRE via COMTEX) -- PSPM | Quote | Chart | News | PowerRating -- Cord Blood America, Inc. (OTCBB: CBAI); PureSpectrum, Inc. (PINKSHEETS: PSPM)
Stock Profiler welcomes investors to sign up at www.stockprofiler.us. to subscribe to our newsletter. Companies wanting to broadcast their message are encouraged to contact Stock Profiler.US, LLC at [phone].

-------------------------------------------

Cord Blood America, Inc. (OTCBB: CBAI | Quote | Chart | News | PowerRating) closed at $0.013 Wednesday, trading 136,795,004 shares.

Company News- January 27, 2009: With the Embryonic Stem Cell Trial Cleared by the FDA as a Key Indicator, Cord Blood America Announces Expansion Plans for Its Stem Cell Storage Program More Stem Cell Agenda News Expected From the Obama Administration This Week

Cord Blood America, Inc. (OTCBB: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said Tuesday that it intends a rapid expansion of its health insurance partnership program to new geographies in 2009. This announcement from Cord Blood America comes on the heels of last week's announcement that the Food and Drug Administration and the U.S. government will allow the world's first test in people of a therapy derived from human embryonic stem cells.

To read the full news release, go to www.stockprofiler.us, click the Headline Tab, enter the ticker symbol and click the news link.

[KlausStoertebeker]

http://www.medicalnewstoday.com/articles/137335.php

"We believe 2009 to be a turning point year for CBAI. We're excited to get going," Mr. Schissler concluded.

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.482.158 von KlausStoertebeker am 30.01.09 14:41:02

....und ich glaube das auch

[KlausStoertebeker]

http://www.moneytv.net/frontpage.htm

...hier kommt das interview !

[jarek_1]

hi all

[Bignugget]

Antwort auf Beitrag Nr.: 36.482.800 von jarek_1 am 30.01.09 15:43:54

Hi jarek

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.482.800 von jarek_1 am 30.01.09 15:43:54

[Bignugget]

Antwort auf Beitrag Nr.: 36.482.953 von KlausStoertebeker am 30.01.09 15:58:54

nice Volume

nice Vola

[jarek_1]

Antwort auf Beitrag Nr.: 36.482.949 von Bignugget am 30.01.09 15:58:29

hi ganz große Verkäufe ,die nehmen alles mit zu Wochenende.

[Bignugget]

Antwort auf Beitrag Nr.: 36.482.953 von KlausStoertebeker am 30.01.09 15:58:54

werdet Ihr noch bedient?

bekommme unten keine mehr

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.482.986 von jarek_1 am 30.01.09 16:01:22

....warte mal die Reaktion aus interview ab....

[split66]

Antwort auf Beitrag Nr.: 36.482.988 von Bignugget am 30.01.09 16:01:27

Servus big

kanst du mir kurz sagen,A/S,O/S,letzte RS
Und wie wird ding hier durchfinanziert(convertibles,warants)?
Gruss

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.482.988 von Bignugget am 30.01.09 16:01:27

...wo ...

[spekulativ]

der dow schaut aber nicht gut aus

[jarek_1]

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.483.013 von split66 am 30.01.09 16:03:31

http://www.slideshare.net/netgenpr/cbai-investor-presentatio…

[Bignugget]

Antwort auf Beitrag Nr.: 36.483.011 von KlausStoertebeker am 30.01.09 16:03:31

genau gibt gleich gegenbewegung


@splitti

habe mich selber noch nicht damit beschäftigt

will sie nciht heiraten

[jarek_1]

wann kommt das Interview

[Bignugget]

Antwort auf Beitrag Nr.: 36.483.026 von spekulativ am 30.01.09 16:05:03

erstaunlich wie sich DoW und CBAI ähneln

aber unsere Pelr eCBAI ist flexibler

[jarek_1]

gleich knallt es richtig runter

[Bignugget]

Antwort auf Beitrag Nr.: 36.483.170 von jarek_1 am 30.01.09 16:18:33

jedenfalls ist es mit einem Super W ausgebrochen

es wird mega explodieren die nächsten Tage und Wochen

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.483.051 von jarek_1 am 30.01.09 16:07:16

...schon wieder ein Megavolumen......100 Millionen schon vorbeigezogen....

[Bignugget]

Antwort auf Beitrag Nr.: 36.483.303 von KlausStoertebeker am 30.01.09 16:30:39

wer heute einsteigt kann sich nächste Woche freuen

[KlausStoertebeker]

....jetzt wirds blutig.....

[KlausStoertebeker]

....aber so liebe ich auch mein Steak

[Gustl24]

sch...OTC -
die orderausführung eine katasstrophe...
die geben mir die stücke einzeln...das dauert
bis weihnachtenalles betrüger

[Bignugget]

Antwort auf Beitrag Nr.: 36.483.431 von KlausStoertebeker am 30.01.09 16:43:23

die zittrigen plus Gewinnmitnahmen sollten draussen sein

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.483.552 von Bignugget am 30.01.09 16:55:21

....sieht so aus als ob die 0,015 hällt.....

[Bignugget]

132 Mio Volume an einem Freitag

ist wahnsinnig

[Bignugget]

Antwort auf Beitrag Nr.: 36.483.589 von KlausStoertebeker am 30.01.09 16:59:30

und das schöne ist

es wird gerade wieder aus dem ask gekauft

[Gustl24]

ich brauch noch 153 zittrige...
bis ich meine order voll hab...

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.483.592 von Bignugget am 30.01.09 16:59:41

vor 15 Minuten

[Bignugget]

Antwort auf Beitrag Nr.: 36.483.608 von Gustl24 am 30.01.09 17:01:30

hey was für eine Ehre

Master Gustl schlägt wieder zu

lass den anderen auch was über

[Gustl24]

die haben mich diese woche schon so verars... bei OTC
ich glaub die wolln mich nicht mehr -
sind mir 12k dollars durch die lappen gegangen -
haben trotz unterschreitung des kauflimits 3 stunden
meine order nicht ausgeführt
wenns heut nicht klappt flieg ich rüber...

[KlausStoertebeker]

....Nähmaschine bei 0,015

[Gustl24]

Antwort auf Beitrag Nr.: 36.483.671 von KlausStoertebeker am 30.01.09 17:07:45

die müssen meine order abarbeiten

[KlausStoertebeker]

Frühstückszeit .....

[Bignugget]

[Bignugget]

[Bignugget]

Antwort auf Beitrag Nr.: 36.483.687 von KlausStoertebeker am 30.01.09 17:09:08

was für ein Maschienka?



gut ist:

kurzfrist abwärtstrend verlassen
Gewinnmitnahmen draussen
hohes Volumen trotz WE
es wird heute 100% nochmal ausbrechen imo

[Bignugget]

oh sorry habe doppel Nähmaschine hingestellt

[Bignugget]

etwas habe ich noch vergessen

gut ist:

kurzfrist abwärtstrend verlassen
Gewinnmitnahmen draussen
hohes Volumen trotz WE
es wird heute 100% nochmal ausbrechen imo
die 15 hält gut
wenn wir mit 15 in WE gehen sollten dann werden wir next week mit hoher wahrscheinlichkeit 0.025 und 0.03 erreichen

[Bignugget]

anschnallen

140 Mio

Volumen stärkster OTC BB heute

[jarek_1]

[Bignugget]

Antwort auf Beitrag Nr.: 36.483.792 von jarek_1 am 30.01.09 17:20:06

wenn wir heute nocheinmal über die 18 schaffen werden die aussteiger hinterherlaufen

[jarek_1]

Antwort auf Beitrag Nr.: 36.483.815 von Bignugget am 30.01.09 17:22:37

bin auch gespannt und wann ist das Interview

[mazuba]

ich hoffe doch das wir höher
schließen als ,015

[Bignugget]

Antwort auf Beitrag Nr.: 36.483.872 von jarek_1 am 30.01.09 17:29:17

muss leider los sorry

ask KlausStörtebeker er hatte den Link reingestellt

bis später

treibt mir den Kurs auf 0.02

[jarek_1]

Antwort auf Beitrag Nr.: 36.483.911 von Bignugget am 30.01.09 17:33:34

ok cu

[KlausStoertebeker]

Cord Blood America, Inc. (OTCBB: CBAI | Quote | Chart | News | PowerRating) CEO Matthew Schissler spoke of the company's recent spike in trading volume.

...weis jemand schon wann ?

[jarek_1]

KlausStörtebeker wann kommt das Interview

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.483.911 von Bignugget am 30.01.09 17:33:34

.....0,02 ehrensache !

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.483.927 von jarek_1 am 30.01.09 17:35:26

http://www.tradingmarkets.com/.site/news/Stock%20News/215104…

MoneyTV, Week of 1/30
Fri. January 30, 2009; Posted: 05:00 AM

http://investorshub.advfn.com/boARDS/board.aspx?board_id=365…

[jarek_1]

noch ne blöde frage wann ist bei uns 5:00 am und danke dir schon mal.

weisst du was da besprochen wird , kann leider kein English

[KlausStoertebeker]

...wir sehen es am Kurs was er gesagt hat...hab leider keine Uhrzeit gefunden...schau mal das Volumen an ...wie abgeschnitten..

[KlausStoertebeker]

Guys this is just healthy trading.

We are making new highs then pulling back to support churning then moving back up. .02 was the resistance level it did not hold so we pulled back to .014 support. I anticipated this that is why I sold at the open at .0195 then bought back in at .015 and .014. Give it a day or two and we will move but I would not want to be on the sideline when the big news hits or when that Time magazine article hits.

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.483.608 von Gustl24 am 30.01.09 17:01:30

http://sec.gov/Archives/edgar/data/1289496/00013544880900006…

[jarek_1]

wo ist spilt66 und Bignugget kommt wieder zu Genta geht durch die decke

[KlausStoertebeker]

....so jetzt haben wir mal mehr Käufer als Verkäufer....

[Gustl24]

sorry leute, aber mein einkaufskörbchen ist
immer noch fast leer...
wir müssen nochmal nach süden abbiegen zum
einkaufen, nicht böse sein...

[Bignugget]

http://www.emergingcompany.com/volume12week32f.htm

[Bignugget]

ich vermute das es zu big käufen kommen könnte zum Schluß wenn die ausgestiegenen Leute sehen, dass es doch nicht weiter abschmiert

viele erwarten das es nächste Woche weiter steigt in ihub

[Bignugget]

alles Kurse >=0.015 ist sehr viel versprechend für nächste Woche

[Gustl24]

Antwort auf Beitrag Nr.: 36.485.688 von Bignugget am 30.01.09 21:27:05

von mir aus kanns jetzt auch steigen...
hab bis vor 10 min. einkaufen müssen...
drecks-otc wollt mir die shares nicht geben -
hab wieder ein dutzend teilausführungen

[Bignugget]

Antwort auf Beitrag Nr.: 36.485.748 von Gustl24 am 30.01.09 21:34:07

kauf doch bestens geht schneller

wäre super wenn wir >=15 schließen könnten

[Bignugget]

0,0155 oder 0,016 ?

[Bignugget]

Antwort auf Beitrag Nr.: 36.485.748 von Gustl24 am 30.01.09 21:34:07

Gustl los hol Dir den rest

[Bignugget]

ca. 200 Mio Volumen

very crazy

[Bignugget]

super

wird ne spannende nächste Woche

n8 @ll

[Gustl24]

Antwort auf Beitrag Nr.: 36.486.026 von Bignugget am 30.01.09 22:08:23

hab schon 3 grosse posis stammzellaktien -
bin voll bis unter die haarspitzen mit biotech -
auch in deutschland

[Bignugget]

Antwort auf Beitrag Nr.: 36.486.040 von Gustl24 am 30.01.09 22:11:17

Zitat aus ihub:

Posted by: cjstocksup Date: Friday, January 30, 2009 4:17:18 PM
In reply to: PENNYSFROMHEAVEN who wrote msg# 1799 Post # of 1805

I agree, volume proceeds price and we have been on top of the volume charts for all penny stocks now for a couple days, next week should be very green. We certainly churned the entire float by churning 500 million shares in the last 2 days. Most say the float is 300 million but 1 said 500 million, even if he was right the whole floattraded between .015 to .025 now so we are set for the next leg up. The last move was up almost 400% if you go by todays closing price so a double or triple from here should be fairly easy early next week.

[KlausStoertebeker]

...ich weis, hört sich jetzt ein bißchen komisch an, aber für mich sahen die letzten Tage so aus als ob sich da einer eingekauft hat ....diese abruppte Volumenende kommt mir doch sehr komisch vor , Millionen von Shares die ganzen Tage und dann 6 Stunden fast nichts, das stinkt doch zum Himmel....da ist einer gefüllt worden und warten auf den Startschuss...nur meine Meinung ...was meint Ihr ?

[KlausStoertebeker]

Cord Blood America Inc. $ 0.02
CBAI -0.00

Short Interest (Shares Short) 13,800
Days To Cover (Short Interest Ratio) 0.0
Short Percent of Float 0.01 %
Short Interest - Prior
Short % Increase / Decrease %
Short Squeeze Ranking™

% From 52-Wk High ($ 0.05 ) -200.00 %
% From 52-Wk Low ($ 0.00 ) 93.33 %
% From 200-Day MA ($ 0.01 ) 33.33 %
% From 50-Day MA ($ 0.00 ) 100.00 %
Price % Change (52-Week) 83.80 %

Shares Float 226,630,000
Total Shares Outstanding 309,474,243
% Owned by Insiders %
% Owned by Institutions %
Market Cap. $ 4,673,061
Trading Volume - Today 200,499,585
Trading Volume - Average 375,300
Trading Volume - Today vs. Average 9999.99 %
Earnings Per Share -0.02
PE Ratio
Record Date 2009-JanB

Sector Healthcare
Industry Medical Laboratories & Research
Exchange BB

[KlausStoertebeker]

BUYINS.NET: CBAI, SUFH, MNCN, IPRFF, CYRR, EJPRY Have Been Removed From Naked Short List Today


http://news.tradingcharts.com/futures/4/8/119767484.html

...zumindest trauen sich die shorts nicht an cbai

[jub2]

Antwort auf Beitrag Nr.: 36.486.336 von KlausStoertebeker am 30.01.09 23:22:17

das schaut aber wirklich nicht so schlecht aus... Ich hatte schon Bedenken ob das hier nicht doch ein pump and dump der nächste Woche schon wieder abtaucht.

das 52 week high schaut ja ausch nicht übel aus, gabs dazwischen noch mal ne Erhöhung?

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.486.367 von jub2 am 30.01.09 23:31:33

Nein ....zumindest habe ich keine gefunden

[KlausStoertebeker]

...so Männer....schönes Wochenende ...und spart eure Kräfte für den Aufstieg nächste Woche

Tchüss und guten8

[Gustl24]

CBAI wird uns noch viiiiiel freude bereiten

ALLE stem cell aktien stehen erst am anfang -
einstieg verpasst wird in einem jahr ende 2009 nur der sagen,
der im februar 2009 nicht eingestiegen ist -
denn dann sehen wir die jetzigen kurse von ganz weit oben,
dann sind die pennystocks zeiten geschichte...

die jetzige weltweite beachtung wird diesen firmen
möglichkeiten eröffnen, die leider vor jahren undenkbar
waren...es werden partnerschaften entstehen...

January 28, 2009: Cord Blood America, Inc. (OTCBB: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that it intends a rapid expansion of its health insurance partnership program to new geographies in 2009. This announcement from Cord Blood America comes on the heels of last week's announcement that the Food and Drug Administration and the U.S. government will allow the world's first test in people of a therapy derived from human embryonic stem cells.


kursziel 1 $ bis ende 2009...ist gewagt aber nicht unrealistisch - haben einen gigantische markt-startposition
in der ersten reihe...

[WBAInvestor]

!

Dieser Beitrag wurde moderiert. Grund: Spammposting

[gerdass]

Antwort auf Beitrag Nr.: 36.487.397 von Gustl24 am 31.01.09 13:29:07

Es ist so, wie es ist

[KlausStoertebeker]

http://quote.barchart.com/texpert.asp?sym=CBAI&code=BSTK


96% buy

[KlausStoertebeker]

Time Magazine Article: Stem Cells


Even during the dark days of the Bush Administration's stem-cell restrictions, Melton helped keep the field going, culturing cells and getting them into labs.


Scientific inspiration can come from anywhere — a person, an event, even an experiment gone awry. But perhaps nothing can drive innovation more powerfully than the passion born of tragedy. Or, in Douglas Melton's case, near tragedy. The co-director of the Harvard Stem Cell Institute (HSCI) is one of the leading figures in the search for cures for presently incurable diseases, and his breakthrough work is challenging many long-held beliefs about the ways biology and human development work.

But it was a very personal experience that brought Melton to stem cells, one that 17 years later he still finds difficult to discuss. When his son Sam was 6 months old, he became ill with what his parents thought was a cold. He woke up with projectile vomiting and before long began taking short, shallow breaths. After several hours, he started to turn gray, and Melton and his wife Gail brought the baby to the emergency room. For the rest of that afternoon, doctors performed test after test, trying to figure out what was wrong. "It was a horrific day," says Melton. (See the top 10 medical breakthroughs of 2008.)

It was not until that evening that a nurse thought to dip a testing strip into Sam's urine and they finally got a diagnosis. The boy's body was flooded with sugar; he had Type 1 diabetes. Then, as now, the disease had no cure, and patients like Sam need to perform for themselves the duties their pancreas cannot — keeping track of how much glucose they consume and relying on an insulin pump to break down the sugars when their levels climb too high. The diagnosis changed not only Sam's life but the lives of his parents and older sister Emma as well. Throughout Sam's childhood, Gail would wake every few hours during the night to check his blood sugar and feed him sugar if his concentration fell too low or give him insulin if it was too high. "I thought, This is no way to live," says Melton. "I decided I was not just going to sit around. I decided I was going to do something."

Trained as a molecular biologist in amphibian development, Melton began the work he pursues today: trying to find a way to make insulin-producing cells by using stem cells. "It was a courageous thing to do because he was at the pinnacle of his career," says Gail. "He brought home textbooks on the pancreas to figure it all out." Nearly two decades later, Melton is convinced that stem cells will be a critical part of new therapies that will treat and maybe cure not only diabetes but also other diseases for which there are no answers today.

Melton's confidence is testament to the extraordinary advances in stem-cell science, some of which have brought the promise of breakthrough therapies for conditions like diabetes, Parkinson's and heart disease closer than ever before. The cells filling petri dishes in freezers and incubators in Melton's lab and others around the world are so vastly different — in provenance, programming and potential — from the stem cells of just two years ago that even the scientists leading this biological revolution marvel at the pace at which they are learning, and in some cases relearning, rules of development. Until recently, the field has revolved around either embryonic stem cells — a remarkably plastic class of cells extracted from an embryo that could turn into any of the body's 200 tissue types — or their more restricted adult cousins, cells taken from mature organs or skin that were limited to becoming only specific types of tissue. On Jan. 23, after nearly a decade of preparation, the Food and Drug Administration approved the first trial of an embryonic- stem-cell therapy for a handful of patients paralyzed by spinal-cord injuries.

But today the field encompasses far more than just embryonic and adult stem cells; it has expanded into the broader field of regenerative medicine, and Melton's lab at Harvard is at the vanguard, bringing the newest type of stem cells, which do not rely on embryos at all, closer to the clinic, where patients will actually benefit. Last summer, Melton stunned the scientific community with yet another twist, finding a way to generate new populations of cells by reprogramming one type of fully mature cell so it simply became another, bypassing stem cells altogether. "If I were in high school, I can't imagine anything more interesting than stem cells," says Melton. "This is so cool. It's so amazing that cells in the body have this potential that we can now unlock by asking question after question."

A Battle Joined
That hidden power in each of us did not become obvious until 1963, when Canadian researchers Ernest McCulloch and James Till first proved the existence of stem cells, in the blood. These cells possess the ability to divide and create progeny — some of which will eventually expire, others that are self-renewing. The pair irradiated mice, destroying their immune cells. They then injected versatile bone-marrow cells into the animals' spleens and were surprised to see a ball of cells grow from each injection site. Each mass turned out to have emerged from a single stem cell, which in turn generated new blood cells.

That discovery led, 35 years later, to James Thomson's isolation of the first human embryonic stem cells, at the University of Wisconsin in 1998. And that milestone in turn inspired researchers to think about directing these cellular blank slates to eventually replace cells that had been damaged or were depleted by disease. The key lay in finding just the right recipe of growth factors and nutrients to induce a stem cell to become a heart cell, a neuron, an insulin-making cell or something else. It would take decades, the researchers all knew, but new therapies were sure to come.

Then, in 2001, everything changed. The use of discarded embryos made embryonic-stem-cell research deeply controversial in the U.S. Citing moral concerns, then President Bush restricted federal funding for the study of human embryonic stem cells. Under the new policy, U.S. government funds could be used only to study the dozens of embryonic cell lines already in existence — many of which proved not to be viable.

The decision sent some leading scientists abroad, to Britain, Singapore and China, where the governments were more receptive to their work. Others who stayed behind but lacked private funding shifted their attention from embryos to the less versatile adult stem cells. Federally backed scientists, like Melton, who continued embryonic work were forced to adopt a byzantine system of labeling and cataloging their cell cultures and equipment so that government money was not used to grow forbidden cells — and government microscopes were not even used to look at them.

Those days may soon be over. Barack Obama campaigned on a promise to lift the research ban and support "responsible oversight" of the stem-cell field. For scientists, that means "we can stop the silliness," says Melton.

As welcome as that change will be, it may be less urgent now — owing primarily to the work of scientists like Melton. While embryonic stem cells remain the gold standard for any treatments that find their way into the clinic, newer techniques using the next-generation stem cells may soon surpass the older ones.

The Fighter
In looks and demeanor, Melton is the quintessential professor, soft-spoken and thoughtful, someone who appears more mentor than maverick. Born and raised on the South Side of Chicago, he developed an early fascination with animal development; that curiosity led to a bachelor's degree in biology at the University of Illinois in 1975, then a second undergraduate degree, in the history and philosophy of science, at Cambridge University on a Marshall Scholarship. Melton remained there for his Ph.D. work, studying under Sir John Gurdon — the first to clone a frog. At Harvard, Melton teaches a frequently oversubscribed undergraduate course on science and ethics, in which he uses his keen sense of logic to provoke. When the class discussed the morality of embryonic-stem-cell research, Melton invited Richard Doerflinger of the U.S. Conference of Catholic Bishops to present arguments against the field. Melton asked Doerflinger if he considered a day-old embryo and a 6-year-old to be moral equivalents; when Doerflinger responded yes, Melton countered by asking why society accepts the freezing of embryos but not the freezing of 6-year-olds.

Clearly, Melton does not shrink from a fight. As Washington's squeeze on stem-cell research tightened in the early part of this decade, he decided to take action, providing life support for what remained of the U.S. stem-cell community. Not convinced that an entire field could make much progress relying on a few dozen cell lines of questionable quality, in 2004 he used funds HSCI receives from the Juvenile Diabetes Research Foundation and the Howard Hughes Medical Institute, as well as from Harvard alumni, and developed a more streamlined method for generating stem-cell lines from embryos. He created more than 70 new ones and has since distributed 3,000 copies to scientists around the country for free.

"Doug drew a line in the sand," says Alan Trounson, president of the California Institute of Regenerative Medicine, the organization charged with dispensing state money for embryonic-stem-cell research. "He turned the tables on an Administration that was incredibly negative toward stem cells and showed [it] we are not going to tolerate being put out of this field by ideological views that we don't think are correct." Melton's motivation was, again, both professional and intensely personal. Two months after Bush announced his ban, Melton's daughter Emma, then 14, also received a diagnosis of Type 1 diabetes.

In part owing to the restrictive U.S. policy, the momentum in stem-cell research seemed to shift overseas. In 2004, South Korean researcher Hwang Woo Suk announced that he had generated the first human embryonic stem cells from healthy people — and in the following year, from afflicted patients themselves — using an abbreviated cloning method. The latter feat would mean that cardiac patients could essentially donate themselves a healthy new heart without fear of rejection.

The news was huge — but it was also a lie. In 2006, Hwang admitted he had falsified his results. (Melton's colleague at HSCI, Kevin Eggan, finally created embryonic stem cells from patients in 2008.) Although Hwang became a pariah, he had the right idea. Melton and others had been trying to do just what the Korean scientist claimed to have done — grow a new population of a patient's own cells. The key to the process is a supply of fresh, good-quality human eggs, which incubate skin cells taken from a patient. Building up such a stockpile, however, proved practically impossible. The egg-extraction process is invasive and carries certain risks; after the state of Massachusetts prevented donors from being compensated for their eggs, out of fear the women would feel coerced, HSCI ended up with only one volunteer out of more than two years of recruiting.

Melton faced mounting political pressure too. In 2004, voters in California approved a measure providing $3 billion in state funding to embryonic-stem-cell research. That threatened to draw scientists in the stem-cell community west, and Melton took pains to foster a "band of brothers" mentality. "I tried to create a cocoon here," he says, "and tell people that your job is to focus on the science. Don't worry what the politicians say." By then, Melton's team was one of only a handful in the country working on embryonic stem cells and was making headway in teasing apart the myriad critical steps needed to guide these impressionable cells into becoming insulin-generating cells. Both as a scientist and as a father, Melton remained convinced that the federal restrictions simply could not survive. He continued to insist that "the science is so significant that it will change the policy."

And then, astonishingly, it did. In June 2006 a modest researcher from Japan made a startling announcement at the International Society for Stem Cell Research conference in Toronto. Shinya Yamanaka quietly described a study in which he took skin cells from a mouse and stirred them in with varying genetic cocktails made from a recipe list of 30 genes known to be important in development. When he hit on the right four genes and inserted them into the cells aboard retroviruses, he wiped the cells clean, reprogramming them and returning them to an embryo-like state without ever creating the embryo. Four genes, he told his audience, was all it took to undo a lifetime's worth of delicate genetic tapestry. No need for eggs, no need for embryos. Could it be that easy? Were the debate and controversy over embryonic stem cells now rendered moot? "It was unquestionably unexpected," says Melton of the breakthrough.

A year later, Yamanaka followed up his work by reporting success with the same four factors in turning back the clock on human skin cells. At about the same time, in Wisconsin, Thomson achieved the same feat using a different cocktail of genes. With those studies, what became known as induced pluripotent stem cells (iPS cells) were suddenly a reality. Never mind the frustratingly fickle process needed to create embryonic stem cells; this was something any molecular-biology graduate student could do. "We figured somebody would have success with reprogramming. We just thought that somebody would come along a generation from now," says Dr. David Scadden, Melton's co-director at HSCI. "Yamanaka threw a grenade at all of that, and now all of the doors are open."

Beyond Stem Cells
Melton, for one, isn't wasting any time before running through those doors. The iPS technology is the ultimate manufacturing process for cells; it is now possible for researchers to churn out unlimited quantities of a patient's stem cells, which can then be turned into any of the cells that the body might need to repair or replace.

Before that can happen, however, Melton wants to learn more about how diseases develop. And iPS cells make that possible too. For the very first time, he can watch Type 1 diabetes unfold in a petri dish as a patient's cells develop from their embryonic state into mature pancreatic cells. The same will be true for other diseases as well. "There is a good reason we don't have treatments for diseases like Parkinson's," says Melton. "That's because the only way science can study them is to wait until a patient appears in the office with symptoms. The cause could be long gone by then, and you're just seeing the end stages." No longer. Now the major steps in the disease process will be exposed, with each one a potential target for new drugs to treat what goes wrong. "This is a sea change in our thinking about developmental biology," says Dr. Arnold Kriegstein, director of the Institute for Regeneration Medicine at the University of California, San Francisco. "I consider it a real transformative moment in medicine."

The true power of reprogramming, however, does not stop with the stem cell. This summer, Melton flirted with the rules of biology once again when he generated another batch of history-making cells, switching one type of adult pancreatic cell, which does not produce insulin, to a type that does — without using stem cells at all. Why, he thought, do we need to erase a mature cell's entire genetic memory? If it's possible to reprogram cells back to the embryo, wouldn't it be more efficient in some cases to go back only part of the way and simply give them an extreme makeover? Using mouse cells, Melton did just that, creating the insulin-producing pancreatic cells known as islets. "The idea now is that you can view all cells, not just stem cells, as a potential therapeutic opportunity," says Scadden. "Every cell can be your source."

Realizing that potential — and with it, the prospect of successful treatments for conditions like Parkinson's or diabetes — may still be a few years away. Even iPS cells have yet to prove that they are a safe and suitable substitute for the diseased cells they might eventually replace in a patient. Ensuring their safety would require doing away with dangerous genes that can also cause cancer, as well as the retroviral carriers that Yamanaka originally used. Melton's team has already replaced two of the genes with chemicals, and he anticipates that the remaining ones will be swapped out in a few years. There are also hints that the iPS cells' short-circuited development makes them different in some ways from their embryonic counterparts. In mice, embryonic stem cells can generate a new mouse clone; iPS cells from the animals have so far stopped short of the same feat, aborting in midgestation, suggesting that some development cues may be missing. "It certainly makes me cautious," says Eggan.

Even if iPS cells do not prove as stable and as versatile as embryonic stem cells when they're transplanted into patients, they remain a powerful research tool. And if nothing else, they will have opened our eyes to the remarkable plasticity of biology and made possible new ways of thinking about repairing and replacing damaged tissues so we may consider not only treating but also curing disease. "It's a wonderful time," says Scadden. "Keep your seat belt on, because this ride is going to be wild."

For patients like Sam and Emma Melton, that ride carries with it the possibility of being free of the insulin pumps and injections they endure to keep their blood sugar under control. "I definitely think about how my life would be different if there is a cure," says Sam. His father is keenly aware that the ability of stem cells and reprogramming science to provide that cure is far from guaranteed. But his initial confidence in the power of the technology hasn't waned. "Everything we learned about stem cells tells us this was a really powerful approach," he says. "It would be a great shame if we let it wither and just go away." Melton, for one, is determined not to let that happen.

[KlausStoertebeker]

[KlausStoertebeker]

even IF the OS is 500 million....it is trading an average of 225 mill a day for the last 5 days!! almost HALF the OS each day!! it has MORE $$ traded each day than the next 50 sub .10 OTCs combined! more trades than the next 8 sub .10 OTCs combined!! the friggen stock is HOT!

[KlausStoertebeker]

It is state law in Georgia...Senate Bill 148, the “Saving the Cure Act. All Doctors MUST inform parents of Cord Blood banking options before third trimester.



HUGE....HUGGGGGE!!!!
I expect more states to follow.

Source: http://www.legis.ga.gov/legis/2007_08/sum/sb148.htm
http://www.savingthecure.com/

[KlausStoertebeker]

http://www.emergingcompany.com/volume13week4qt.mov


interview

[KlausStoertebeker]

Auch sehr interessant :

Two totally different businesses. CBAI makes $5M in revenues Whereas ACTC p$sses money down the drain in the name of research and development. What are ACTC's revenues????

Cord Blood is the 4th largest private stem cell storage bank in the U.S.

We derive our revenues from an initial Fee for the service: anywhere upto $2000
then there are montly fees for storage: For few hundred dollars

Per customer!

CBAI VIDEO
http://www.youtube.com/watch?v=sQEkIbeEzUc

[KlausStoertebeker]

CBAI 3 NEW VIDEOS:


CBAI VIDEO
http://www.youtube.com/watch?v=sQEkIbeEzUc


http://www.youtube.com/watch?v=ZTxLegm7M5Y


http://www.youtube.com/watch?v=P_J0rXxgoPc

[KlausStoertebeker]

Here's the current OS (based on factual information derived from the last 10Q and investor presentation)

As of Sep-07
309,000,000

Added May-08
20,270,270
2,837,238

Added Jul-08
64,370,200
30,370,553

Added Sep-08
17,907,102
9,655,531

Added Jan-09
47,562,096

TOTAL OS
501,972,990

Your welcome. We've definitely churned through all the OS. That means new floor is .01 or above, imo.

[KlausStoertebeker]

Auch schön :

Huh? You're smoking crack....IN BLACK and WHITE Dec '09

"Prospectus"...and it's as recent as the 2007/2008 stuff you posted ROFL.





Common Stock Issued Before Offering
301,982,188 shares of our common stock are issued and outstanding as of the date of this prospectus.




Common Stock Issued After Offering (1)
349,544,284 shares of common stock.

Use of Proceeds
We will not receive any proceeds from the sale of the common stock by the selling shareholders.

http://www.pinksheets.com/edgar/GetFilingHtml?FilingID=63426…

[Bignugget]

Habt Ihr diese News noch von Freitag gesehen????????????


Stockwire.com: Cord Blood America, Inc. (OTCBB: CBAI) just released some important news.

Jan 30, 2009 (M2 PRESSWIRE via COMTEX) -- Cord Blood America, Inc. (OTCBB: CBAI), just announced Expansion Plans for Its Stem Cell Storage Program.
A dedicated Chat Room for Cord Blood America, has been created at STOCKWIRE.com to discuss this news event.

Visit the following link to begin chatting with your fellow shareholders: http://www.stockwire.com/chat" target="_blank" rel="nofollow ugc noopener">http://www.stockwire.com/chat

----------------------------------------------------------

SANTA MONICA, CA -- Cord Blood America, Inc. (OTCBB: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that it intends a rapid expansion of its health insurance partnership program to new geographies in 2009. This announcement from Cord Blood America comes on the heels of last week's announcement that the Food and Drug Administration and the U.S. government will allow the world's first test in people of a therapy derived from human embryonic stem cells. For more information, see the social media news room at http://www.intelligendo.com.

Founder and CEO Matthew Schissler, in reviewing the domestic stem cell industry, predicts that 2009 will be an excellent, milestone year for stem cell storage companies, including CBAI. "Now is the right time. We have focused our business on three primary locations for several years, developing deep relationships with health insurance providers to become their recommended source for storage of umbilical cord blood stem cells."

Mr. Schissler says Cord Blood America's stem cell storage subsidiary, CorCell, will attempt to enter into contracts with two or three more geographic health insurance providers, which would double the company's current health insurance provider base.

"With a national health insurance plan and stem cell agenda as two of the primary topics from the new administration, we see a marriage of the insurance companies possibly paying for stem cell storage on the horizon, even if it is on a limited basis for high risk families. By developing the insurance sales channel, we feel we are positioning ourselves for long term success in becoming a globally dominant stem cell storage company."

Mr. Schissler went on to say that the growth will have limited cost because all infrastructure needed has been put into place over the course of many years.

CBAI has a history of being able to finance its growth, with the most recent funding of $4 million transacting in July of 2008. "With a very low cash burn, we feel we're well financed for the next few years," Schissler commented. "We'll use this time to get cash flow positive and reduce debt while growing both organically and through accretive acquisitions."

The company also is reporting tremendous success in engaging its clients, prospective clients, shareholders and prospective investors via social media with the help and intuition of NetGenPR (www.netgenpr.com). Cord Blood America is currently on Twitter, Facebook and Intelligendo, and soon to be available on FriendFeed. Cord Blood America's address on Twitter is http://www.twitter.com/cbai. "The conversation has begun. Groups from all over are discussing the impact of stem cells on every day life. We're glad we can lead and moderate this information, while trying to be a stem cell company of the people."

As previously reported, from 2003 to 2007, CBAI focused on growth. In 2008, the Company changed its tactics attempting to de-lever the company while becoming purely a stem cell storage company, and in the process de-emphasizing its non-core family advertising business.

As such, Cord Blood America has reported through first nine months: -- Gross profits for the first nine months have increased to $1.8 million, a 54 percent margin, compared to a 42 percent margin in 2007.

-- SGA is down nearly $900,000, a 23 percent savings.

-- Loss from operations is down nearly 20 percent.

-- Loss per share is down 60 percent, from 0.05 to 0.02.

"We believe 2009 to be a turning point year for CBAI. We're excited to get going," Mr. Schissler concluded.

About:

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/. To see our social media news room go to http://www.intelligendo.com

----------------------------------------------------------

About Stockwire:

Stockwire is one of the largest communities for Micro Cap Investors. We are the only place on the internet to provide LIVE CHAT ROOMS for dedicated stocks.

We have also pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.

The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.

Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.

As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.

While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the National Association of Securities Dealers ("NASD") at www.nasd.com. The NASD has published information on how to invest carefully at its web site.

Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml

Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.

From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.

Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com. To the degrees enumerated herein, this newsletter and website should not be regarded as an independent publication.

The editor, members of the editor's family, and/or entities with which the editor is affiliated aside from Stockwire Research Group Inc. (SRGI) itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE.COM.

We often accept restricted shares of company stock; by SEC regulations, restricted shares cannot be sold into the market for a period of at least one year from the time that the shares are issued. In such cases, we detail in the Disclaimer the specific term of any restrictions. We also receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. In such circumstances, we specify on our Disclaimer the terms of the options received. On occasion, we also accept free-trading shares in a company that we cover. However, by policy we generally do not buy or sell any shares of a company's stock within three trading days after any such company's profile, commentary, or other company-specific information is disseminated on Stockwire.com Web site. In cases where we do trade within the three day window, our volume will never represent more than 5% of the daily volume, thereby minimizing any effect we could have on the potential price movement.

While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm." target="_blank" rel="nofollow ugc noopener">http://www.stockwire.com/disclaimer_profiles.htm.

CONTACT: The Stockwire Group Tel: [phone] e-mail: [e-mail] WWW: http://www.stockwire.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire

[Bignugget]

Heute fliegt hier der Deckel

Warum?

Super News
steigende Kurse bei steigenden Volumen
letzten Freitag 200 Mio Volumen zum WE

200 Tagelinie nach oben durchbrochen
es gibt wenige werte an der OTC Schrottplatz, die etwas noch hergeben
Buy Empfehlung



Schnallt euch heute an

von mir bekommt das Ding heute Strong Buyyyyyyyyyyyy!!!!!!!!

[Bignugget]

Ausbruch wird die Tage perfekt

[Bignugget]

ob man welche noch in Berlin bekommt?

[Bignugget]

Offensichtlich steht dort nichts im Ask

also müssen wir die Eröffnung drüben abwarten

schade

[Gustl24]

Antwort auf Beitrag Nr.: 36.492.261 von Bignugget am 02.02.09 08:40:24

wenn ich mir den chart so anschaue,
möcht ich dahin wo der kurs schonmal stand - 1$,
bis mr.bush diese forschung austrocknen wollte,
sehe insb. durch partnerschaften mit versicherungen
nationwide brutales potential - und cord blood
scheint das auch recht clever anzustellen

strongeeeeest buy

[Bignugget]

Antwort auf Beitrag Nr.: 36.493.096 von Gustl24 am 02.02.09 10:45:01

die Jungs drüben sind sehr euphorisch

Kurszile von 0.15-0.30 soll innerhalb der nächsten Wochen soll möglich sein.

Ich sage why not aber vorsichtig OTC

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.493.165 von Bignugget am 02.02.09 10:54:53

...sehe ich ähnlich..bei aller euphorie ...immer schön mitdenken !

....die Möglichkeiten sind allerdings GIGANTISCH !

[Gustl24]

Antwort auf Beitrag Nr.: 36.493.165 von Bignugget am 02.02.09 10:54:53

das ist ein ganz entscheidenter punkt aus der meldung
ende letzter woche für mich:

...Cord Blood America, Inc. (OTCBB: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that it intends a rapid expansion of its health insurance partnership program to new geographies in 2009...

wenn mit obama diese forschung intensiviert wird und
versicherer diese leistung bezuschussen explodieren
die einnahmen dieser firma von heut auf morgen...
die können sofort loslegen, die müssen nicht ein medikament
durch jahrelange klinischen studien bringen...
die werden ihre einnahmen im 1.halbjahr 2009 vervielfachen
der bürger liest im febr.2009 time magazine...die bekannteste
zeitung der usa - titelgeschichte stem cells-forschung ->
er sagt, das lass ich in meiner familie machen, wenn die medizin
hier ihre forschung intensiviert , die versicherer + blue cross
dahinterstehen...super sache...
boooom steigt die rakete...
das ist ein OTC-wert der wirklich die chance hat über 1$
zurückzukommen in 2009!!!!

[Bignugget]

Antwort auf Beitrag Nr.: 36.493.409 von Gustl24 am 02.02.09 11:29:12

[Gustl24]

Antwort auf Beitrag Nr.: 36.493.986 von Bignugget am 02.02.09 12:39:55

sag ich doch biggi:

der bürger liest im febr.2009 time magazine...die bekannteste
zeitung der usa - titelgeschichte stem cells-forschung ->
er sagt, das lass ich in meiner familie machen...

bin selbst arzt, wirklich...ist ne klare sache...

[KlausStoertebeker]

versicherer diese leistung bezuschussen explodierendas tun Sie bereits in Oklahoma ...

[Gustl24]

Antwort auf Beitrag Nr.: 36.494.514 von KlausStoertebeker am 02.02.09 13:51:02

und hoffentlich bald nationwide =
potential X 100
-> aktienkurs X 100 ????

p.s. weiss schon, dass usa keine 100 bundesstaaten hat,
aber oklahoma ist ja nicht so wichtig, aber sicher richtig von dir,
d.h. der erste schritt existiert bereits in oklahoma -
jetzt ausweitung nationwide...

[KlausStoertebeker]

StemCells, Inc (STEM) Added to the Ludlow Biotech Index
Staff Reporter
Last Updated:- Jan. 29, 2009 - 4:45pm EST

(NEW YORK)-- Ludlow Capital Group, Inc., a equity research and venture firm based in New York's Financial District, announced they have listed StemCells, Inc (NASD: STEM) as a new component to the Ludlow Biotech Stock Index. http://www.ludlowcapital.com/indices/biotech/

Tom Bustamante, the Managing Director of Ludlow Capital Group, Inc. commented "We are pleased to announce StemCells as a new component to our biotech stock index as the companies research in the stem cell arena should provide for additional breath for our biotech tracking index."

In additional to StemCells, Ludlow BioVentures also announced the addition of Aastrom Biosciences (ASTM) to the Ludlow Biotech Index as one of the small cap leaders within the stem cell sector.

"Our venture division, Ludlow BioVentures, is very bullish on the stem cell sector, not just for the potential of the lifting of the federal funding ban by the Obama Administration, but due to the breakthrough potential the industry holds in the coming years. We are currently working with several new stem cell projects and feel this sector has more upside ahead in the next few years."

Among StemCells, Inc. (STEM), Ludlow BioVentures also has research alerts on Neuralstem, Inc. (CUR), Aastrom Biosciences (ASTM), Geron, Corp. (GERN), and several small cap stem cell plays such as Cord Blood America, Inc. (CBAI), Stem Cell Therapy Intl Corp. (SCII), and Advanced Cell Technology (ACTC).

Ludlow BioVenture anticipates conducting a live investor conference for institutional investors in Manhattan covering the stem cell, and biotech sector in early March. For more information on upcoming events, and biotech research updates register at - http://www.ludlowcapital.com/request/biotech.html

About Ludlow BioVentures

Ludlow BioVenture's is a network of institutional and individual high-net worth accredited investors interested in the biotechnology sector as an investment target. Ludlow BioVentures is a full service investment advisory firm which serves the needs of both private and public biotechnology companies. http://www.ludlowcapital.com/bioventures/

[Bignugget]

[Gustl24]

Antwort auf Beitrag Nr.: 36.495.272 von Bignugget am 02.02.09 15:34:39

möcht jetzt mal ein 5 mio. balken in blau
richtung 0.02 sehen -kommt bald

[Bignugget]

Antwort auf Beitrag Nr.: 36.495.317 von Gustl24 am 02.02.09 15:40:31

her damit

[Gustl24]

auch ein netter link:

http://tradingstemcells2009.blogspot.com

hab mal das wichtigste rauskopiert:

... I expect this stock will move from $0.015/share to $.05/share in the next two weeks...

dann hoff mer mal, dass er recht behält

[Bignugget]

Antwort auf Beitrag Nr.: 36.495.480 von Gustl24 am 02.02.09 15:58:07

durchaus realistisch da es letzte Woche ohnehin die 0.025 erreicht hat

[KlausStoertebeker]

...unsere Perle läuft bis jetzt gegen den Trend bei Stem Cells.....sind sonst fast alle rot ...

[Bignugget]

Antwort auf Beitrag Nr.: 36.495.480 von Gustl24 am 02.02.09 15:58:07

so Gustl startschuss ist gegeben


anschnallen

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.495.272 von Bignugget am 02.02.09 15:34:39

0,018

[Bignugget]

Antwort auf Beitrag Nr.: 36.495.573 von KlausStoertebeker am 02.02.09 16:07:45

yep so schauts Stoertebeker

das soll was heissen

Dieser enorme Druck war schon an Freitag Volumen zu erkennen

[KlausStoertebeker]

....auch heute wieder starkes Volumen

[Bignugget]

so ein Mist ausgerechnet am Rallytag habe ich dringend was zu erldigen


aber ich gönne euch den Spass

0.025 wir kommen

Hat einer ne Raketenbild???

[Bignugget]

[Gustl24]

Antwort auf Beitrag Nr.: 36.495.589 von Bignugget am 02.02.09 16:09:14

die sollen mal die skalierung ändern -
was interessiert mich die 0,01..nach dem komma

[KlausStoertebeker]

Volumen vor 15 Minuten

Buy Voll. 15 Millionen

Sell Voll. 6 Millionen


...soweit sogut

[Bignugget]

[Bignugget]

Antwort auf Beitrag Nr.: 36.495.638 von KlausStoertebeker am 02.02.09 16:12:55

das schöne ist, es ist noch sowas von unentdeckt

Diese Woche werden wir bestimmt die Rankingliste Top50 führen

Das noch das Vorspiel audf das was uns noch bevor steht

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.495.677 von Bignugget am 02.02.09 16:16:05

4b in grün

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.495.709 von KlausStoertebeker am 02.02.09 16:20:25

....sorry druckfehler

[KlausStoertebeker]

...der DOW kommt auch zurück...

[Bignugget]

Antwort auf Beitrag Nr.: 36.495.709 von KlausStoertebeker am 02.02.09 16:20:25

Volumenstärkste OTCBB auf ihub List
Rank 3 ihub Toplist wird Nr.1 werden

Es fehlen noch die richtigen News

Lasst die Amis noch Frühstücken

Es wird noch doller knallen

[Bignugget]

muss leider los

passt mir auf den Kurs auf

hoffe wir treffen uns bei 0.025

bis später

[Gustl24]

viele stem cell aktien wurden ja heut zu handelsbeginn
richtig nach unten gedrückt - schwacher dow -
da ist die performance von CBAI in der ersten handelsstunde
schon beeindruckend - + gutes volumen...
an " guten" handelstagen haben wir noch mehr spass

möcht aber schon auch, dass die anderen stem`s auch steigen-
bin ja gut positioniert-aber CBAI scheint richtig druck
nach oben zu haben!!

auf eine grüne woche

[Bignugget]

Antwort auf Beitrag Nr.: 36.495.847 von Gustl24 am 02.02.09 16:37:45

dabin i wieder

wasn los ? läuft nicht wie erhofft aber gewöhnlich ist der Montag auch nicht der Umsatzstärkste Tag

lieber langsam und sicher steigen

morgen und übermorgen solls auch steigen

[Bignugget]

[Gustl24]

Antwort auf Beitrag Nr.: 36.497.624 von Bignugget am 02.02.09 20:39:29

sorry, kann grad nicht steigen,
bin schon wieder am einkaufen hier,
hab schon wieder mein einkaufskörbchen
dabei - und ich hab ein kauflimit gesetzt

[Gustl24]

schau dir mal die nähmaschine an -
das ist mein kauflimit

[Bignugget]

Antwort auf Beitrag Nr.: 36.497.722 von Gustl24 am 02.02.09 20:54:59

wie viele Körbchen hast Du?

[Gustl24]

Antwort auf Beitrag Nr.: 36.497.851 von Bignugget am 02.02.09 21:19:02

ein gaaaaaaaaanz grosses -
aber die drecks otc gibt mir wieder alles einzeln

[Bignugget]

Antwort auf Beitrag Nr.: 36.497.889 von Gustl24 am 02.02.09 21:26:33

schöne käufe wieder zum Schluß

auch mit dem Volumen kann man zufrieden sein

[Bignugget]

Antwort auf Beitrag Nr.: 36.497.889 von Gustl24 am 02.02.09 21:26:33

eine News die Tage und der Deckel fliegt weg

jeder wartet auf ne explosion

[Bignugget]

Antwort auf Beitrag Nr.: 36.497.889 von Gustl24 am 02.02.09 21:26:33

mach schnell den Körbchen voll

100 Mio sollten hete drin sein

[Bignugget]

sehr schön

[Bignugget]

Zitat aus ihub:

Posted by: cjstocksup Date: Monday, February 02, 2009 2:21:56 PM
In reply to: JV44 who wrote msg# 2178 Post # of 2227

We are all going to be very grateful in the weeks and months ahead, remeber Stem cell stocks are just getting started, remember FSLR when it first started around $2.00 then it went to almost $300.00 and ran for a very long time. That is exactly what is going to happen with Stem cell stocks once they get going and more and more news flows. they will be unstoppable. Institutions will be loading up, it already stated with us with Blue Cross Blue Shield buying 15 million shares so far. It should be interesting in the weeks and mnths ahead just to see exactly who all is buying and loading up for the future. We are the future.

[Bignugget]

The week has gotten off to a great start!

See you tomorrow, looking forward to an early AM breakout back over .02 on our way to .03.

get ready for a huge run ahead in the days and weeks and months going forward. This is just the begining for us.

[Gustl24]

es gibt nicht viele aktien mit dieser performance gestern



aber das war erst der anfang-ich bleibe ganz long

[KlausStoertebeker]

...da hat noch ein Mutiger in Berlin zugeschlagen....mmmhhh ....mal sehen wies heute läuft......vielleicht schaffen Sie es ja wieder gegen den Trend...wird aber schwer.

[Gustl24]

hab mal wieder die us-boards durchgelesen -
durchwegs fast nur positive beiträge,
viele auch positiv aus sicht betroffener eltern,
basher werden gnadenlos runtergebügelt...auch
aus ethischer sicht nicht erwünscht...
engagement von blue cross shield wird immer
wieder hervorgehoben...sieht gut aus...
werde rücksetzer für zukäufe nützen

[Pokerlui007]

ab wann gibts denn wieder aktien??

[KlausStoertebeker]

...wird schwer heute...starkes Volumen wieder aber viel rot...

[Pokerlui007]

ich will AKTIEN!!!

[Pokerlui007]

sooo order ist zu 0,014 gesetzt...

[Pokerlui007]

und wurde bedient sehr schön...wir sehen uns dann bei 0,10€ in 2 Wochen...

[Gustl24]

das volumen heut ist brutal - 30-40 millionen shares
in der ersten handelsstunde -
da wollen viele noch günstig rein - JEDERbis auf die shorties will hier noch günstig rein

hab noch mal zugekauft - ein bisschen teuer 0,017$
aber das juckt mich in einem jahr nicht mehr

[Pokerlui007]

seh ich auch so...in einem Jahr steht hier der 1€ oder 1$...

[KlausStoertebeker]

Antwort auf Beitrag Nr.: 36.498.227 von Bignugget am 02.02.09 22:07:32

[Bignugget]

Antwort auf Beitrag Nr.: 36.505.299 von KlausStoertebeker am 03.02.09 20:53:27

heute war GNTA Tag

morgen ist wieder CBAI Tag

[Tamaone]

!

Dieser Beitrag wurde moderiert. Grund: Spammposting

[Pokerlui007]

bis jetzt hat sich ja bei uns garnichts getan, mal sehn was ab 15.30Uhr abgeht...hoffe wir starten Richtung 0,02$!!

[Bignugget]

es wird ordentlich geschüttelt

schaumermal wie die gegenreaktion ausschauen wird

[Bignugget]

bitte so ein chart wie bei GNTA

[Pokerlui007]

mist bin ich wohl bei 0,014€ etwas zu früh rein...naja denke dass wir in 1-2 Monaten wo ganz anders stehen...oder was meint ihr?

[Bignugget]

Antwort auf Beitrag Nr.: 36.511.332 von Pokerlui007 am 04.02.09 16:13:56

da kannst Du Dich drauf verlassen

wo wir aber stehen werden ???? kannst genauso aus dem Fenster gucken und selber verraten

wenn wir das wüssten wären wir schon super reich


aber wenn es News gibt werden wir bestimmt viel höher stehen imo

[Pokerlui007]

wo bist du denn rein!?

[Bignugget]

könnte bis 0.010 runter gehen

[Bignugget]

so das sollte es wohl sein mit der korrektur

jetzt kann es wieder nach Norden gehen

[Bignugget]

[tomcat17]

Weiß jemand wann Obama das Stammzellengesetz ändern will?

Gruss tomcat17

[Ventrikel]

Antwort auf Beitrag Nr.: 36.514.108 von tomcat17 am 04.02.09 20:26:00

Innerhalb der ersten 60 Tage nach seiner Inauguration, könnte also
durchaus noch bis Mitte März dauern.
Tatsache ist aber, daß wohl noch immer nicht begriffen wurde, warum unter den Stemmcell Companies nur ACTC und CBAI von den Underdogs das Rennen machen werden.
Hier geht es um eine embryonale Datenbank, bei ACTC um humanes
embryonales Genom, aus dem Progenitorzellen entnommen und transferiert werden, und zwar in pathologisch verändertes Gewebe.
Ich sage Euch als Mediziner, daß nur CBAI und vor allem ACTC
von den OTC-Werten überproportional von der Aufhebung des
"Stammzellbans" profitieren werden.
(Wenngleich ich vor einigen Wochen von CBAI nicht überzeugt war).
Keine Kauf- oder Verkaufsempfehlung.

Abwarten, Tee trinken, die Zeit wird das klären.

Mfg Vent.

[Bignugget]

Antwort auf Beitrag Nr.: 36.514.552 von Ventrikel am 04.02.09 21:16:34

8-K Filing nach SEC

http://www.pinksheets.com/edgar/GetFilingHtml?FilingID=63800…

[Gustl24]

Antwort auf Beitrag Nr.: 36.514.787 von Bignugget am 04.02.09 21:43:52

wenn ich das richtig versteh nur personelle
umbesetzung - ein direktionsmitglied geht aus
familiären gründen...oder?

[Bignugget]

Antwort auf Beitrag Nr.: 36.514.913 von Gustl24 am 04.02.09 21:54:15

yes

[Gustl24]

Antwort auf Beitrag Nr.: 36.514.552 von Ventrikel am 04.02.09 21:16:34

hab heut nochmal nachgeladen - jetzt reicht aber wirklich

jetzt sitz ich hier ganz long...aber so ne kleine
meldung über einen contract mit ein paar
insurance companies würd ich nehmen in den nächsten tagen...

[Pokerlui007]

ask schon bei 0,016€ aktuell!! wie kann das sein bei dem schlusskurs gestern drüben?

[Gustl24]

Antwort auf Beitrag Nr.: 36.516.083 von Pokerlui007 am 05.02.09 08:45:27

die deutschen zahlen halt
noch für qualität
in usa schon brutale zockermentalität...
5000 shares rein, dann wieder raus...cowboys halt

[Pokerlui007]

hehe

ask ist echt krass am schwanken hier bei uns...fiel dann auf 0,011 zurück um jetzt wieder bei 0,014 zu stehen. hoffe die amis ziehen dann mal nach!!

[rem53]

Antwort auf Beitrag Nr.: 36.518.015 von Pokerlui007 am 05.02.09 12:29:37

http://biz.yahoo.com/prnews/090205/la67191.html?.v=1

Press Release Source: Cord Blood America, Inc.


In Analyst Interview, Cord Blood America Says Stem Cells Now Front and Center for Researchers and Investors
Thursday February 5, 8:00 am ET


SANTA MONICA, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI - News), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that Matthew Schissler, founder and CEO, in an interview with analyst Francis Gaskins, explained that the Company is very close to becoming cash flow positive.
ADVERTISEMENT


The complete interview is available at http://www.stoxrox.com/cbai-feb-b.mp3 . "2009 is a tipping point year for Cord Blood America. We will continue our organic growth strategy, adding new health insurance partners and possible new acquisitions, while continuing to reduce debt," Mr. Schissler said.

Cord Blood America's CEO said he was encouraged that more Federal spending on stem cell research under President Obama could lead to more stem cell therapies which, in turn, will lead to more families storing stem cells. "The stem cell agenda is front and center with the new Administration," Mr. Schissler said.

Cord Blood America's CEO also referenced the cover story of the new Time magazine, which cited breakthroughs using stem cells to treat Parkinson's, heart disease and diabetes. "Investors should understand, in storing umbilical cord blood stem cells, we have a significant biological annuity with low bad debt ratio, strong gross profits, and a low cost structure in place that will allow us to take full advantage of the expected increase in the storage of stem cells," the Company's founder said.

[Bignugget]

hier kommt was ganz großes die Tage und Monate


Hammer News


schnallt euch schonmal an

[Bignugget]

Matthew Schissler, founder and CEO, in an interview with analyst Francis Gaskins, explained that the Company is very close to becoming cash flow positive.
ADVERTISEMENT


The complete interview is available at http://www.stoxrox.com/cbai-feb-b.mp3 . "2009 is a tipping point year for Cord Blood America. We will continue our organic growth strategy, adding new health insurance partners and possible new acquisitions, while continuing to reduce debt," Mr. Schissler said.

[jarek_1]

Antwort auf Beitrag Nr.: 36.519.686 von Bignugget am 05.02.09 15:35:02

guten Tag zusammen

[Bignugget]

Antwort auf Beitrag Nr.: 36.519.955 von jarek_1 am 05.02.09 16:00:46

Hi jarek schön das Du da bist


Hier geht was Junge

Die News sehen sehr vielversprechend aus

Hier wird die nächsten Tage und Wochen der Deckel wegfliegen


0.15-0.30 langfristig gesehen ist nur meine spekulative Meinung

[Gustl24]

Antwort auf Beitrag Nr.: 36.520.055 von Bignugget am 05.02.09 16:08:50

dann hätt ich 400000 k plus gemacht -
dann fahr ich mal zu garr winters und polier ihm die platte

[Bignugget]

je mehr Amis die News lesen und einsacken lassen desto höher werden wir steigen


Festhalteeeeeeeeeeeeeeeeeeeenn

[Bignugget]

[Gustl24]

Antwort auf Beitrag Nr.: 36.520.131 von Bignugget am 05.02.09 16:16:34

biggi,
gib zu, du hast um kurz nach 16.00 nochmal
nachgelegt - die 4 mio. waren doch deine!!

[Bignugget]

Antwort auf Beitrag Nr.: 36.520.214 von Gustl24 am 05.02.09 16:26:25

jeder kann kaufen

[Bignugget]

Antwort auf Beitrag Nr.: 36.520.214 von Gustl24 am 05.02.09 16:26:25

es will ausbrrechen undzwar senkrecht nach oben

18 bis 20 ist heut drin

[hadesitem]

ich grüße euch ihr seit ja super drauf.....ich will auch kaufen geht es nur in berlin????

[Bignugget]

Antwort auf Beitrag Nr.: 36.520.289 von hadesitem am 05.02.09 16:33:46

i kofe in US schneller und stressfrei

[hadesitem]

Antwort auf Beitrag Nr.: 36.520.311 von Bignugget am 05.02.09 16:35:22

kann ich nicht bin bei der ccitibank........was versprichst du dir von dem wert ich hab mal kurz paar seiten überflogen......die firma gibt es erst seit 07 oder sehe ich das falsch??

[mazuba]

jetzt gehts hoch

[Pokerlui007]

geil geil geil da lobe ich mir nun doch meinen einstieg zu 0,014€!!

[Bignugget]

Antwort auf Beitrag Nr.: 36.520.344 von hadesitem am 05.02.09 16:38:04

betrue hier keine Leute

sehe nur das was ich sehe

und glaube an das was ich lese


risiko freudig bin ich auch

bevor ich mich schlau geamcht habe kann die story vorbei sein

also handeln nicht zögern ist mein motto

[Bignugget]

Antwort auf Beitrag Nr.: 36.520.384 von Pokerlui007 am 05.02.09 16:42:31

das ist doch noch garnichts

da waren wir auch vor den News vor paar Tagen

richtig Geil wird es wenn wir die 25 überschreiten

[Pokerlui007]

das ask ist schon bei 0,018 und das bid noch bei 0,009€???

[Tom06]

über meinen Brooker nur Handelsplatz Berlin möglich.
Und die zocken einen mit 0,018 zum Kauf ab.

Also der Spread ist mir zu gross :

[jarek_1]

bin am bord

[jarek_1]

[mazuba]

Antwort auf Beitrag Nr.: 36.520.443 von jarek_1 am 05.02.09 16:47:29

[Pokerlui007]

jetzt könnt ihr wieder zu 0,014€ rein...müsst euch bloß beeilen...so viele gibt es ja nicht und auch nur berlin

[jarek_1]

Antwort auf Beitrag Nr.: 36.520.472 von Pokerlui007 am 05.02.09 16:49:25

in berlin ging es nicht, habe bei amis gekauft

[Pokerlui007]

zu welchen kurs??

[Bignugget]

Antwort auf Beitrag Nr.: 36.520.506 von jarek_1 am 05.02.09 16:51:28

hast Dich nichtmal bedankt Du bist mir ein Freund

[Gustl24]

zieht ja endlich wieder an

[Bignugget]

Antwort auf Beitrag Nr.: 36.520.539 von Gustl24 am 05.02.09 16:52:57

was hat euch der Biggi gesagt

[rem53]

Antwort auf Beitrag Nr.: 36.520.426 von Tom06 am 05.02.09 16:46:07

Kauf in den usa.
Pass bloss auf,den Fehler hab ich früher mal gemacht,das bid nicht zu tief ansetzen,sonst kriegst Du nur eine Teilausführung.
Vielleicht ein bisschen beobachten.


http://investorshub.advfn.com/boARDS/board.aspx?board_id=365…

[jarek_1]

Antwort auf Beitrag Nr.: 36.520.528 von Bignugget am 05.02.09 16:52:35

sorry du bist der beste , danke dir

[hadesitem]

so ich bin auch mal dabei mit 0.013 in berlin..... und saumäßig gespannt was hier geht.....

[jarek_1]

ich muss jetzt Baden, habe um 20 Uhr Tischtennis spiel

[Bignugget]

nice Volume aber noch nicht genug

[Bignugget]

Antwort auf Beitrag Nr.: 36.520.659 von jarek_1 am 05.02.09 17:02:59

dann geh mal Baden

[beacker38]

was für ne Sau wird denn hier durchs Dorf getrieben??

[sneake]

hallöchen zusammen.geht hier noch was?

[Bignugget]

Antwort auf Beitrag Nr.: 36.520.734 von sneake am 05.02.09 17:08:38

Heeeeey Sneake ist auch da

dann kann es richtig losgehen

aber ersteinmal eine kleine verschnaufpause


wir schaffen schon die 18

[sneake]

Antwort auf Beitrag Nr.: 36.520.780 von Bignugget am 05.02.09 17:14:23

hehe muß erst mal meine order ausgeführt werden solang kanns noch ein wenig verschnaufen.

[Bignugget]

wenn die 145 durch ist kommt die 18


schade muss gleich auch los (Training)


würde vorher gern aber noch ne Fahnenstange sehen

[sneake]

Antwort auf Beitrag Nr.: 36.520.839 von Bignugget am 05.02.09 17:20:00

shcreib mir deine handynummer und ich tu dich informieren falls was geht.dann macht das training doppelt soviel spaß.

[Tom06]

Antwort auf Beitrag Nr.: 36.520.635 von hadesitem am 05.02.09 17:01:09

Geht bei Dir auch nur Berlin?

Beim Verkauf bieten Sie Dir gerade 0,09 an, d.h. ein grosser Spread!

Wieso ist hier nur Berlin als Handelsplatz gelistet?

[Bignugget]

Antwort auf Beitrag Nr.: 36.520.879 von sneake am 05.02.09 17:22:36

007 Top Secret

mach mir keine sorgen

Trotzdem sehr nett von Dir

Danke


Um CBAI mache ich mir keine sorgen

das eigentliche soll wohl in März kommen wenn Onkel Obama sein Go gibt

dann sollen hier Kurse von 0.20-0.30 möglich sein

solange bleibt es für mich ein spekulatives OTC wert

[Bignugget]

In Analyst Interview, Cord Blood America Says Stem Cells Now Front and Center for Researchers and Investors
Thursday February 5, 2009, 8:00 am EST

Yahoo! Buzz Print Related:Cord Blood America Inc.
SANTA MONICA, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI - News), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that Matthew Schissler, founder and CEO, in an interview with analyst Francis Gaskins, explained that the Company is very close to becoming cash flow positive.
Related Quotes
Symbol Price Change
CBAI.OB 0.01 +0.00


{"s" : "cbai.ob","k" : "c10,l10,p20,t10","o" : "","j" : ""} The complete interview is available at http://www.stoxrox.com/cbai-feb-b.mp3 . "2009 is a tipping point year for Cord Blood America. We will continue our organic growth strategy, adding new health insurance partners and possible new acquisitions, while continuing to reduce debt," Mr. Schissler said.

Cord Blood America's CEO said he was encouraged that more Federal spending on stem cell research under President Obama could lead to more stem cell therapies which, in turn, will lead to more families storing stem cells. "The stem cell agenda is front and center with the new Administration," Mr. Schissler said.

Cord Blood America's CEO also referenced the cover story of the new Time magazine, which cited breakthroughs using stem cells to treat Parkinson's, heart disease and diabetes. "Investors should understand, in storing umbilical cord blood stem cells, we have a significant biological annuity with low bad debt ratio, strong gross profits, and a low cost structure in place that will allow us to take full advantage of the expected increase in the storage of stem cells," the Company's founder said.
About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI - News) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI - News), visit our website at http://www.corcell.com/. For investor information, visit www.cordblood-america.com.


CONTACT:
Paul Knopick
E & E Communications
949/707-5365
[e-mail]

[Bignugget]

so jetzt bin ich aber wirklich weg

viel Spass noch euch allen

[sneake]

Nix los mehr was?
Hier habt ihr ein wenig was zum lesen.

http://topics.nytimes.com/top/news/business/companies/cord-b…

[Bignugget]

Antwort auf Beitrag Nr.: 36.521.791 von sneake am 05.02.09 19:02:56

Rom wurde auch nicht an einem Tag erbaut

es wird sich prächtig entwickeln

Richtung stimmt schonmal

[jarek_1]

moin bin wieder zurück bin auch zufrieden mit denn Kurs und morgen ist auch ein tag aber leider Freitag.hmm aber in Tischtennis haben wir wenigstens ein Sieg geholt

[Pokerlui007]

auf einen 2. grünen tag in folge...vor 15.30 wird sich hier wohl nix weiter tun!

[hadesitem]

Antwort auf Beitrag Nr.: 36.525.044 von Pokerlui007 am 06.02.09 09:32:50

bin gestern zu 0.013 rein.....was kann man hier erwarten.....???

[Pokerlui007]

glaube tiefer als 0,009€ gehts wohl erstmal nicht mehr...denke und hoffe das man hier in 2-3 Monaten ver-X-fachen kann. Mein persönliches Kursziel sind erstmal die 10Cent...danach mal kieken!

[hadesitem]

Antwort auf Beitrag Nr.: 36.525.488 von Pokerlui007 am 06.02.09 10:24:43

das wäre ein sogenannter tenbagger naja drin bin ich und sollte es up gehen um so besser, ich danke für deine antwort hast du noch irgendwelche quellen ???

[Pokerlui007]

nee ist mehr ein bauchgefühl von mir deshalb bin ich auch mal rein...auf mein bauchgefühl konnte ich mich aber zuletzt ganz gut verlassen (z.b. bin ich bei barclays für 0,54€ rein) aber das heißt nicht dass es hier auch klappen muss.

Ich denke hier ist soviel potential vorhanden, dass es im grunde nur nach oben gehen kann. wer hier ein bißchen zeit mitbringt macht auf jeden fall seine gewinne, wieviele es sein werden sehen wir ja dann...


good luck!

[hadesitem]

Antwort auf Beitrag Nr.: 36.525.937 von Pokerlui007 am 06.02.09 11:17:09

uns allen viel glück, meist ist es so das man in einen wert recht zeitig investiert ist bevor die masse aufmerksam wird.......hoffen wir das es hier so ist.......

[Gustl24]

grosse rolle wird das medieninteresse insb.
ausgabe febr.09 time magazine sein -
das ist DIE zeitschrift weltweit - number one...
bin überzeugt, dass über das frühjahr 09
diese medizin brutal an interesse gewinnen wird,
da wird ein dominoeffekt auf andere medien entstehen -
die schreiben doch alle voneinander ab
gut finde ich, dass CBAI nicht jahrelang forschen muss
um an diesem boom zu partizipieren, denn die stehen
jetzt schon in der ersten reihe und haben sich
voll auf dieses segment fokussiert -
die können aus dem stand ihre gewinne vervielfachen,
und dann boooom steigt die rakete...
mir gefällt auch, dass das management sofort reagiert
und dieses mediale interesse sofort in baren gewinn
der company umzusetzen, sieht alles recht clever aus

[Gustl24]

kursziel 10 cent sehe ich als durchaus realistisch
bis ende märz 09 -
hab selten auf ihub ein dermassen positives echo
einer otc -aktie gelesen...
durchweg kursziele zwischen 0,05 - 2 $ binnen 09.
wenn die company in einen positiven cash flow in diesem quartal
kommt, und das ist sehr realistisch, dann sehe ich hier kurse
zwischen 20-30 cent für möglich binnen 6-9 monaten -
ist kein zock für mich, seh ich sogar als investment...

[hadesitem]

Antwort auf Beitrag Nr.: 36.526.414 von Gustl24 am 06.02.09 12:09:00

na das sind ja zahlen......wenn es so kommt wäre das der hammer bei 0.20 € ist das schon der oberknaller aber 2$ da brauch ich ein arzt......

[sneake]

Antwort auf Beitrag Nr.: 36.526.414 von Gustl24 am 06.02.09 12:09:00

dann müßen sie sich aber anstrengen.denn bisher machen die fast soviel verlust wie umsatz wenn ich das richtig gelesen habe.
aber ist wohl erst mal nebensächlich wenn der trend stimmt.

[hadesitem]

Antwort auf Beitrag Nr.: 36.526.553 von sneake am 06.02.09 12:25:46

wenn sich die gesetze lockern und man was verdienen kann wird es vieleicht auch investoren geben.......oder??
jedenfalls könnten die geschäfte in gang kommen....

[Bignugget]

Antwort auf Beitrag Nr.: 36.526.553 von sneake am 06.02.09 12:25:46

hast Du die News von gestern garnicht gelesen???

der CEO ist mehr als Optimistisch drauf


In Analyst Interview, Cord Blood America Says Stem Cells Now Front and Center for Researchers and Investors
Thursday February 5, 2009, 8:00 am EST

Yahoo! Buzz Print Related:Cord Blood America Inc.
SANTA MONICA, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI - News), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that Matthew Schissler, founder and CEO, in an interview with analyst Francis Gaskins, explained that the Company is very close to becoming cash flow positive.
Related Quotes
Symbol Price Change
CBAI.OB 0.01 +0.00


{"s" : "cbai.ob","k" : "c10,l10,p20,t10","o" : "","j" : ""} The complete interview is available at http://www.stoxrox.com/cbai-feb-b.mp3 . "2009 is a tipping point year for Cord Blood America. We will continue our organic growth strategy, adding new health insurance partners and possible new acquisitions, while continuing to reduce debt," Mr. Schissler said.
Cord Blood America's CEO said he was encouraged that more Federal spending on stem cell research under President Obama could lead to more stem cell therapies which, in turn, will lead to more families storing stem cells. "The stem cell agenda is front and center with the new Administration," Mr. Schissler said.

Cord Blood America's CEO also referenced the cover story of the new Time magazine, which cited breakthroughs using stem cells to treat Parkinson's, heart disease and diabetes. "Investors should understand, in storing umbilical cord blood stem cells, we have a significant biological annuity with low bad debt ratio, strong gross profits, and a low cost structure in place that will allow us to take full advantage of the expected increase in the storage of stem cells," the Company's founder said.
About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI - News) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI - News), visit our website at http://www.corcell.com/. For investor information, visit www.cordblood-america.com.


CONTACT:
Paul Knopick
E & E Communications
949/707-5365
[e-mail]

[sneake]

http://www.stoxrox.com/cbai-feb-b.mp3

[hadesitem]

Antwort auf Beitrag Nr.: 36.526.946 von Bignugget am 06.02.09 13:09:59

dann kann es ja up gehen, also ich bin mehr als gespannt......

[Pokerlui007]

bin auch gespannt ob hier heute schon eine kleine rakete zündet...

[hadesitem]

interesant wird es erst wenn die masse aufmerksam wird mit sämtlichen zockern die es gibt, dann sind wir schnell bei 0.05 und mehr......also 200K kann man für den anfang hier haben oder nicht.....

[Gustl24]

Antwort auf Beitrag Nr.: 36.528.051 von hadesitem am 06.02.09 15:04:15

dann mach mal vor deine 2 noch ne 2 dann haste meine
stückzahl - jeder cent plus find ich richtig klasse

[Bignugget]

Antwort auf Beitrag Nr.: 36.528.301 von Gustl24 am 06.02.09 15:28:06

jetzt haben wir den Besitzer des großen blauen Balkens von gestern gefunden

[Bignugget]

es geht weiter

[Bignugget]

[hadesitem]

Antwort auf Beitrag Nr.: 36.528.301 von Gustl24 am 06.02.09 15:28:06

wie jetz 2,2 mio.....?????
das heisst bei 0.10 cent bist du schon durchs ziel....ich könnte 1 mio kaufen hab ich aber den mut nicht dazu

[Gustl24]

Antwort auf Beitrag Nr.: 36.528.340 von Bignugget am 06.02.09 15:32:15

mensch biggi,
gegenüber dir bin ich doch kleininvestor...
du hast bestimmt schon ab anfang januar gesammelt

[Gustl24]

die richtung stimmt erstmal - und die farbe der balken
auch - gestern haben sie schon auf ihub gezählt -
sehr viele zukäufe im vergleich zu verkäufen -
hier wartet doch jeder auf gute zeiten...

[vomarc79]

jiuhu!

Bin noch mit dabei, allerdings liegt mein aktueller EK noch über dem RT-Kurs. Wenn es so weiter geht, allerdings nicht mehr lang

Greetinx

Marc

[Gustl24]

Antwort auf Beitrag Nr.: 36.528.418 von hadesitem am 06.02.09 15:39:44

gut gerechnet - vor 10 cent verkauf
ich hier nicht - solang die story der company stimmt...
die bemühen sich redlich - CEO gibt immer ein paar
nette news in den letzten tagen raus -
gefällt mir

[hadesitem]

Antwort auf Beitrag Nr.: 36.528.450 von Gustl24 am 06.02.09 15:42:39

naja eins ist fakt wenn es durch den regierungswechsel zu einer anderen gesetzgebung gekommen ist kann das der zock des jahrhunderts werden........wenn hier die storry stimmt und das unternehmen zu geld kommt klingelts im geldbeutel auch bei uns aktionären......

[hadesitem]

Antwort auf Beitrag Nr.: 36.528.490 von Gustl24 am 06.02.09 15:46:03

sollte ich mir meine mio holen........
wie gesagt der zock des jahrhunderts

[Bignugget]

Antwort auf Beitrag Nr.: 36.528.524 von hadesitem am 06.02.09 15:50:30

es will wieder ausbrechen

Es gibt gute zahlen drüben

Börse ist Positiv gestimmt

von wegen Freitag

da geht noch was imo

bin weiterhin dabei

[sneake]

gibts hier kein party smilie?

[Bignugget]

Antwort auf Beitrag Nr.: 36.528.556 von sneake am 06.02.09 15:53:58

während GNTA weiter abschmiert zieht unsere Perle davon


It's Party Time

[Gustl24]

Antwort auf Beitrag Nr.: 36.528.524 von hadesitem am 06.02.09 15:50:30

ich möcht dich nicht wo reinquatschen - will fair sein...
aber ich bleib hier echt loooong

[Bignugget]

Antwort auf Beitrag Nr.: 36.528.556 von sneake am 06.02.09 15:53:58

Hey Sneake musste wegen Dir Verwarnt werden

weil ich Dich Gestern in Fremdthreads auffindig machen wollte

naja jarek und Dich habe ich schliesslich doch gefunden


geniesst euer Party

[vomarc79]

sieht heute wirklich sehr, sehr gut aus bislang!

Hatte mir eigentlich Sorgen gemacht wegen Freitag; aber wie es scheint kann die kleine aber feine News doch einiges beirken was den Kurs angeht!

Mal sehen wo wir heute Abend stehen!

[Gustl24]

jetzt wär ja mal ne kleine rakete angebracht...
los stellt das ding rein - teil soll ja oben bleiben

[Ventrikel]

Kann bitte jemand den RT-chart reinstellen, bin in der Arbeit und kann nur zeitweise reinschauen. Danke im voraus!!!


Mfg Vent

[Bignugget]

Antwort auf Beitrag Nr.: 36.528.590 von Gustl24 am 06.02.09 15:57:17

sehr fair von Dir


jeder sollte selber wissen was er/sie tut

lasst euch nicht unbedingt von unserer euphorie mitreissen

investiert immer soviel wie ihr nur entbehren könnt

übrigens gilt das für alle invests


es macht spass; es macht spass; es macht spass

[Tom06]

Antwort auf Beitrag Nr.: 36.528.591 von Bignugget am 06.02.09 15:57:17

naja - wenn das Ding wegfliegt, dann war´s ne gute Tat

[Bignugget]

[sneake]

Antwort auf Beitrag Nr.: 36.528.591 von Bignugget am 06.02.09 15:57:17

hehe

naja next time schickst mir ne BM

ps.hat sicher aber gelohnt die verwarnung oder?

[Bignugget]

Sper Volumen wieder

ihub OTCBB ranking

1.

[Bignugget]

Antwort auf Beitrag Nr.: 36.528.653 von sneake am 06.02.09 16:01:29

so kann man es auch sehen

[Bignugget]

Antwort auf Beitrag Nr.: 36.528.653 von sneake am 06.02.09 16:01:29

amis sind auch ganz schön hot


Get ready for .03 to .05 next week, we are going to be so hot.

[Bignugget]

ladies & gents please fasten your seat belts



this ride is about to shoot straight up ! then dip just a tad before we propell into the great blue skies ! And as always thank you for flying CBAI !

[Tom06]

Antwort auf Beitrag Nr.: 36.528.840 von Bignugget am 06.02.09 16:17:04

irgendwie hat´s den Vogel gerade ein wenig aus der Bahn gebracht

aber wird wohl nur ne kurze Zwischenlandung geben

[hadesitem]

ich sag ja das kann der invest des jahrhunderts werden........nur ich zögere wieder meine mio zu kaufen nächste woche werde ich aber min 200K nachschießen....

[Bignugget]

Antwort auf Beitrag Nr.: 36.528.907 von hadesitem am 06.02.09 16:22:36

man darf die story nicht kurzfristig betrachten

mindestens März sollte man abwarten da angeblich von Obama aus ein Signal ausgehen soll was Stammzellforschung angeht


daher warte ich die weiteren Super News ab

[Gustl24]

der link wird allein heute für schub sorgen:

http://washingtontimes.com/news/2009/feb/06/obama-guarantees…

ist ja ne seriöse quelle - mr. president wird uns
sowas von anschieben

[Gustl24]

Antwort auf Beitrag Nr.: 36.528.931 von Bignugget am 06.02.09 16:24:38

dann kannst du das wort "angeblich" jetzt aus
dem letzten post von dir streichen -
obama says: YES, we can...

[Bignugget]

Antwort auf Beitrag Nr.: 36.528.950 von Gustl24 am 06.02.09 16:26:10

Yes he Can

http://washingtontimes.com/news/2009/feb/06/obama-guarantees…

[Bignugget]

Antwort auf Beitrag Nr.: 36.528.985 von Gustl24 am 06.02.09 16:28:50

Ach Du Jemineeeeeeeeeeeeeeeeeeeeeeeeeeeee

das sehe ich erst jetzt


Obama 'guarantees' stem cell approval
Stephen Dinan (Contact)
Friday, February 6, 2009
Comment
Print
Font Size Share
Got a Question?
You Report
Click-2-Listen
Buzz up!
President Barack Obama speaks to the House Democratic Issues Conference on Thursday in Williamsburg. Associated Press

WILLIAMSBURG| President Obama on Thursday gave lawmakers his "guarantee" he will sign an executive order overturning President Bush's embryonic stem cell research policy.

Meeting with House Democrats holding a retreat here, Mr. Obama answered a question from Rep. James R. Langevin, a Rhode Island Democrat who is a paraplegic, by saying he will sign the order, according to three sources who were in the closed-door part of the meeting.

"I guarantee you that we will sign an executive order for stem cells," Mr. Obama said, according to the sources who requested anonymity because they were not authorized to talk about the closed-door portion of the meeting.

Mr. Obama said the executive order would be coordinated with Congress on timing, and said it was important that Congress also pass a law codifying his order so that a future president couldn't simply reverse the policy back.

In 2001, Mr. Bush signed an order early in his presidency allowing federal funding for embryonic stem cell research, though limiting it only to lines that existed at that point. Congress has twice passed a bill expanding funding beyond Mr. Bush's policy but he vetoed it, and lawmakers were unable to override it.

The research is theoretically promising because embryonic stem cells can turn into any kind of human cell, which holds out the possibility of miracle cures via the production of patient-specific healthy cells untainted by disease or degeneration.

However, harvesting the cells destroys the embryo, which has raised moral criticism of the research as a form of murder the reason for Mr. Bush limiting the research to lines where the decision about life and death already had been made. Research done outside U.S. federal auspices also has yielded few tangible results.

In Williamsburg, the private Q&A portion Mr. Obama spoke in public for 22 minutes about his stimulus spending bill, ditching his prepared remarks for much of the time to deliver a fiery plea to Democrats and a mocking rebuke to Republicans.

He blamed "cable chatter" for distorting the debate, and said, "aren't you all tired of that stuff?"

"I don't care whether you're driving a hybrid or an SUV, if you're headed for a cliff you've got to change direction," he said. "That's what the American people called for in November, and that's what we intend to deliver."

In fielding questions, Mr. Obama was asked how he planned to keep his millions of supporters engaged going forward, and he said he was counting on the Democratic National Committee to manage that effort. He said he was about to launch "Obama 2.0."

It was the president's first trip out of Washington since being inaugurated, and marked his first flight as president aboard Air Force One. He came back to the press cabin at the back of the plane to talk with reporters as the plane was taxiing for liftoff, and he was sporting a brand new blue Air Force One crew jacket with his name stitched on the breast.

"I’ve got my spiffy jacket so I thought I’d come and show it off," he said.

"It’s good to see you guys. What do you think about this spiffy ride? It’s not bad," he told the press, who he visited in their rear compartment before the flight took off.

He also raved about the view from Marine One, which ferries the president from the lawn of the White House to Andrews Air Force Base, where Air Force One always awaits him.

"The helicopter was very smooth, very impressive, you go right over the Washington Monument and then, you know, kind of curves in by the Capitol. It was spectacular."

[spekulativ]

http://www.youtube.com/watch?gl=DE&hl=de&v=QI7NsXwurQg

[hadesitem]

Antwort auf Beitrag Nr.: 36.528.993 von Bignugget am 06.02.09 16:30:05

mein englisch ist scheiße.....
wer lust hat kann mal paar stichpunkte auf deutsch reinstellen......

[Bignugget]

heute fliegt der Deckel weg

Die News ist noch nicht angekommen

ich habe es auch erst soeben gelesen

[Bignugget]

Hohhohohohohoooooooooooo
gleich werden die MM's ein Problem haben

[jarek_1]

moin zusammen bin grad von der Arbeit und sehe wunderbare News .

[jarek_1]

[hadesitem]

auf deutsch paar stichpunkte......sinngemäß bitte....

[Bignugget]

bitte auf die schnelle ein Google Übersetzung

kann es leider von hier aus nicht (kein Zugriff)


************************************************

[jarek_1]

grüss dich wo ist Andelko und merege

[Bignugget]

Stocks Jumps on Stimulus Hopes

DoW; Nasdq; Dax alle positiv


Selbst wenn es wegen Wochende nicht sich im Kurs spigeln sollte

eins ist Gewiss

next week geht die Party hier weiter


So ihr lieben nun muss ich wieder zum Training

bis später

[Bignugget]

http://de.advfn.com/p.php?pid=staticchart&s=NO^CBAI&p=0&t=15…

[hadesitem]

ich mache feierabend schönes we und das unser hammerinvest uns alle reich macht

[jarek_1]

gleich platzt es über die 0,017 weg

[jarek_1]

[jarek_1]

Mazuba, Klasse einstieg, bin gestern zu 0,014 rein

[jarek_1]

in USA

[Tom06]

Antwort auf Beitrag Nr.: 36.529.538 von jarek_1 am 06.02.09 17:16:10

na na na na - sooo schnell geht´s nun auch wieder nicht;

aber wenn wir jeden Handelstag ca. 20-30% machen, dann passt es auch;

von Deckel wegfliegen sehe ich jedenfalls nichts

[spekulativ]

was geht denn nun ab

[jarek_1]

Antwort auf Beitrag Nr.: 36.529.743 von Tom06 am 06.02.09 17:34:36

Geduld mein sohn

[jarek_1]

Der Hammer ist , habe die Aktie im depot und wenn ich sie zum verkauf geben will wegen shortis , damit die Aktie nicht beliehen werden kann , steht da Handelbare 0 stück .

Habe bei meiner Bank angerufen und denn dies verklickert.

Antwort ist ein technischer Fehler, muss sie durch Telefonbanking zum verkauf geben, der Hammer ist bin umgezogen und weiss nicht wo meine Telefonbanking ist, kommt erst Donnerstag neu.

Also fahre ich jetzt Blind und kann es nur durch Fax bestätigen sonst in Moment gar nicht.

Muss heute noch Fax schreiben.

Ich liebe Deutsche Bank

[jarek_1]

[Vaterland]

Antwort auf Beitrag Nr.: 36.529.817 von jarek_1 am 06.02.09 17:42:06

geht mir genau so,habe jetzt in USA gekauft

[jarek_1]

Antwort auf Beitrag Nr.: 36.529.852 von Vaterland am 06.02.09 17:45:40

hast du auch DB

[Vaterland]

Antwort auf Beitrag Nr.: 36.529.867 von jarek_1 am 06.02.09 17:47:04

genau die

[jarek_1]

ne anders bist du auch bei DB

[Tom06]

Handelt ihr um in USA zu kaufen über die DB?

Dachte E-Trade wäre diesbezüglich zu empfehlen?

[jarek_1]

Antwort auf Beitrag Nr.: 36.529.852 von Vaterland am 06.02.09 17:45:40

hast sie erst Morgen im Depot und kannst sie nur durch Telefonbanking verkaufen , ist doch ein Witz von DB

na ja bin gelassen nach denn News.

viele verkaufen grade wegen WE und gewinne zu nehmen verstehe es gar nicht aber heute noch dick im Plus

[Vaterland]

Antwort auf Beitrag Nr.: 36.529.925 von Tom06 am 06.02.09 17:52:44

ich kaufe normal nie drüben,aber versuche seit rund

2 Stunden in Bremen zu kaufen,geht einfach nicht

[jarek_1]

Antwort auf Beitrag Nr.: 36.529.925 von Tom06 am 06.02.09 17:52:44

wenn mir noch einer hier von DB schreibt,platzt mir der sack

[mazuba]

Antwort auf Beitrag Nr.: 36.529.988 von jarek_1 am 06.02.09 17:58:07

zack zack

[Vaterland]

Antwort auf Beitrag Nr.: 36.529.939 von jarek_1 am 06.02.09 17:53:49

Wertpapierkauf DB

Beim Ausführen der Order ist folgender Fehler aufgetreten.
Die Orderfunktion steht momentan nicht zur Verfügung. Bitte versuchen Sie es zu einem späteren Zeitpunkt.

[Tom06]

Antwort auf Beitrag Nr.: 36.529.969 von Vaterland am 06.02.09 17:56:29

ich trade über die Ing-Diba; dort kann ich dieses Papier leider nur in Berlin handeln....und die haben mir nen Kurs von 0,013€ angeboten;

also bin ich im Minus ...... NOCH

würde aber gerne auch in USA handeln, deshalb bin ich auf der Suche nach einem Anbieter.

[spekulativ]

Antwort auf Beitrag Nr.: 36.529.969 von Vaterland am 06.02.09 17:56:29

in bremen

[jarek_1]

[jarek_1]

die Amis sind einfach nur Vollpfosten aber cool bleiben

[rem53]

Antwort auf Beitrag Nr.: 36.530.022 von Tom06 am 06.02.09 18:01:44

Hi
Bin bei sbroker,da ich halt nur ein Kleinanleger bin,komme ich damit gut zurecht.
1 Transaktion im Quartal,keine Depotgebühren.
Handel in den USA mit einbegriffen.
Es gibt bestimmt günstigere Alternativen,allerdings,ich bin kein Profi,mir reicht es.

[Tom06]

Ist irgend ne Meldung durch?

[jarek_1]

auf der anderen Seite das Gap muss zu und das ist bei gestrigen SK

[jarek_1]

[Gustl24]

Antwort auf Beitrag Nr.: 36.530.128 von Tom06 am 06.02.09 18:13:03

keine meldung - nur otc -verbrecherbörse -
aber solang ein kurs im plus ist kann ich
damit leben, und das schlimmste:
ich wette die makler an der otc sind
die grössten verbrecher, und das ist mein ernst

aber die 10 cent sehen wir hier so
sicher wie das amen in der kirche - nur abwarten,
2-3 monate

[jarek_1]

sorry GAP 0,0145 gestern Höchstkurs

[koronis]

Das Teil könnte heute noch auf Tageshoch fliegen. Der Gesamtmarkt stimmt auf jeden Fall.

[Gustl24]

kurs gedrückt und jetzt wird billig eingekauft -
die kumpels vom mm haben bestimmt nicht bei 0.016$
gekauft - die werden jetzt ausgeführt, schöne
blaue balken

[rp75]

wenn man in berlin kauft ist es ja viel zu teuer!!

wahnsinn

[jarek_1]

die kämpfen wie sau, um denn kurs unten zu halten, das wird nicht mm

[sorby]

Antwort auf Beitrag Nr.: 36.530.265 von rp75 am 06.02.09 18:28:13

Sie wird aber nur in Berlin/Bremen gehandelt!!

[rp75]

Antwort auf Beitrag Nr.: 36.530.343 von sorby am 06.02.09 18:37:03

ich weiß aber warum wird die um soviel teurer gehandelt als im army land

[jarek_1]

hier alle News.

http://www.pinksheets.com/pink/quote/quote.jsp?symbol=CBAI#g…

[sorby]

Antwort auf Beitrag Nr.: 36.530.436 von rp75 am 06.02.09 18:43:47

Weil die MM die Anleger abzocken wollen, schau Dir doch nur den Spread von 30% an. Des weiteren hat Berlin auch so seine Eigenarten und im Augenblick hat sie noch das Monopol. Wenn die Aktie ein bißchen besser bekannt wird, werden auch die anderen Börsenplätze sie anbieten und dann ist der Spread nicht mehr so groß.
Merke: Die wollen nur Dein Geld in Form von Gebühren und Spread!!!

[jarek_1]

[rem53]

Schon gelesen?

http://biz.yahoo.com/ap/090206/gene_drug_altered_animals.htm…

[rp75]

Antwort auf Beitrag Nr.: 36.530.489 von sorby am 06.02.09 18:48:27

das ist blöd, denn ich kann diese aktie nur in berlin handeln weil ich nicht die möglichkeit habe in usa zu handeln.

welchen broker hast du??

[Gandyx]

Geht ja schon wieder langsam aufwärts.

[Gandyx]

Antwort auf Beitrag Nr.: 36.530.489 von sorby am 06.02.09 18:48:27

Das hat nicht unbedingt was mit MM´s zu tun. Ich kann ja auch für z.B. 0,013 Euro verkaufen.

[sorby]

Antwort auf Beitrag Nr.: 36.530.731 von Gandyx am 06.02.09 19:10:53

Bloß wirst Du sie dann nicht los bekommen, wenn der Kurs sich nicht bewegt, wie die letzten zwei Stunden.

[jarek_1]

so Leute immer mit der ruhe jeder entscheidet für sich selbst und ich habe mein Order durch gefaxt 0,04 ist aber nur meine Meinung. Muss jetzt auch weg cu all

[Gandyx]

Ich finde der Kurs hält sich ganz gut, dafür das heute Freitag ist...

[jarek_1]

so 0,015 sind drin ich muss jetzt wirklich weg cu all

[Bignugget]

Antwort auf Beitrag Nr.: 36.531.106 von jarek_1 am 06.02.09 19:50:18

naja aufgerundet passt schon

[Gustl24]

war halt doch ein typischer freitag -
später sand im getriebe - kleinzocker,die noch kasse gemacht
haben -
wünsche den kleinzockern ne bombemnews am wochenende
und ne saftige eröffnung am montag zwischen
0.017 und 0.018 $ - dann können sie dem kurs
wieder hinterherhecheln

[Bignugget]

mit den folgenden beiden News haben wir heute einen sehr stabilen Fundament gelegt, worauf wir nächste Woche aufbauen können.

es ist völlig normal das die zocker Ihre Gewinner abgesichert haben aber wer sich in die Materie eindecken kann wird begreifen das es kein Strohfeuer sein wird mit CBAI

Sie wird uns die kommenden Wochen und Monate sehr große Gewinne ermöglichen nur meine Meinung

keine kauf oder verkauf Empfehlung




In Analyst Interview, Cord Blood America Says Stem Cells Now Front and Center for Researchers and Investors
Thursday February 5, 2009, 8:00 am EST

Yahoo! Buzz Print Related:Cord Blood America Inc.
SANTA MONICA, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI - News), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that Matthew Schissler, founder and CEO, in an interview with analyst Francis Gaskins, explained that the Company is very close to becoming cash flow positive.

Related Quotes
Symbol Price Change
CBAI.OB 0.01 +0.00


{"s" : "cbai.ob","k" : "c10,l10,p20,t10","o" : "","j" : ""} The complete interview is available at http://www.stoxrox.com/cbai-feb-b.mp3 . "2009 is a tipping point year for Cord Blood America. We will continue our organic growth strategy, adding new health insurance partners and possible new acquisitions, while continuing to reduce debt," Mr. Schissler said.

Cord Blood America's CEO said he was encouraged that more Federal spending on stem cell research under President Obama could lead to more stem cell therapies which, in turn, will lead to more families storing stem cells. "The stem cell agenda is front and center with the new Administration," Mr. Schissler said.

Cord Blood America's CEO also referenced the cover story of the new Time magazine, which cited breakthroughs using stem cells to treat Parkinson's, heart disease and diabetes. "Investors should understand, in storing umbilical cord blood stem cells, we have a significant biological annuity with low bad debt ratio, strong gross profits, and a low cost structure in place that will allow us to take full advantage of the expected increase in the storage of stem cells," the Company's founder said.
About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI - News) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI - News), visit our website at http://www.corcell.com/. For investor information, visit www.cordblood-america.com.


CONTACT:
Paul Knopick
E & E Communications
949/707-5365
[e-mail]




*******************************************************************


Obama 'guarantees' stem cell approval
Stephen Dinan (Contact)
Friday, February 6, 2009
Comment
Print
Font Size Share
Got a Question?
You Report
Click-2-Listen
Buzz up!
President Barack Obama speaks to the House Democratic Issues Conference on Thursday in Williamsburg. Associated Press

WILLIAMSBURG| President Obama on Thursday gave lawmakers his "guarantee" he will sign an executive order overturning President Bush's embryonic stem cell research policy.

Meeting with House Democrats holding a retreat here, Mr. Obama answered a question from Rep. James R. Langevin, a Rhode Island Democrat who is a paraplegic, by saying he will sign the order, according to three sources who were in the closed-door part of the meeting.

"I guarantee you that we will sign an executive order for stem cells," Mr. Obama said, according to the sources who requested anonymity because they were not authorized to talk about the closed-door portion of the meeting.

Mr. Obama said the executive order would be coordinated with Congress on timing, and said it was important that Congress also pass a law codifying his order so that a future president couldn't simply reverse the policy back.

In 2001, Mr. Bush signed an order early in his presidency allowing federal funding for embryonic stem cell research, though limiting it only to lines that existed at that point. Congress has twice passed a bill expanding funding beyond Mr. Bush's policy but he vetoed it, and lawmakers were unable to override it.

The research is theoretically promising because embryonic stem cells can turn into any kind of human cell, which holds out the possibility of miracle cures via the production of patient-specific healthy cells untainted by disease or degeneration.

However, harvesting the cells destroys the embryo, which has raised moral criticism of the research as a form of murder the reason for Mr. Bush limiting the research to lines where the decision about life and death already had been made. Research done outside U.S. federal auspices also has yielded few tangible results.

In Williamsburg, the private Q&A portion Mr. Obama spoke in public for 22 minutes about his stimulus spending bill, ditching his prepared remarks for much of the time to deliver a fiery plea to Democrats and a mocking rebuke to Republicans.

He blamed "cable chatter" for distorting the debate, and said, "aren't you all tired of that stuff?"

"I don't care whether you're driving a hybrid or an SUV, if you're headed for a cliff you've got to change direction," he said. "That's what the American people called for in November, and that's what we intend to deliver."

In fielding questions, Mr. Obama was asked how he planned to keep his millions of supporters engaged going forward, and he said he was counting on the Democratic National Committee to manage that effort. He said he was about to launch "Obama 2.0."

It was the president's first trip out of Washington since being inaugurated, and marked his first flight as president aboard Air Force One. He came back to the press cabin at the back of the plane to talk with reporters as the plane was taxiing for liftoff, and he was sporting a brand new blue Air Force One crew jacket with his name stitched on the breast.

"I’ve got my spiffy jacket so I thought I’d come and show it off," he said.

"It’s good to see you guys. What do you think about this spiffy ride? It’s not bad," he told the press, who he visited in their rear compartment before the flight took off.

He also raved about the view from Marine One, which ferries the president from the lawn of the White House to Andrews Air Force Base, where Air Force One always awaits him.

"The helicopter was very smooth, very impressive, you go right over the Washington Monument and then, you know, kind of curves in by the Capitol. It was spectacular."

[Bignugget]

Antwort auf Beitrag Nr.: 36.532.224 von Gustl24 am 06.02.09 22:21:01

hier der Beweis, dass es nächste Woche weiter steigen wird

der Kurs hat sich nach einer Konsolidierung wieder erholt und wir haben heute trotz Wochenende steigende Kurse bei steigendem Volumen und haben grün abgeschlossen

Freue mich schon auf nächte Woche

[rem53]

Antwort auf Beitrag Nr.: 36.532.327 von Bignugget am 06.02.09 22:41:28

http://www.wallstreetnewscast.com/news/stem_index.html

Ludlow Biotech Index

[Gandyx]

Sieht ja alles schwer nach nem grünen Montag aus. Wie seht Ihr das?

[UH1d]

Test!?

[Bignugget]

Antwort auf Beitrag Nr.: 36.536.742 von rem53 am 08.02.09 16:27:24

würde mich schwer wundern, wenn CBAI nach dem Obama versprechen keine News bringen würden die Tage imo

[hadesitem]

keiner da heute.......etwas über eine stunde und es geht wieder los und hoffentlich in die richtige richtung......

[Bignugget]

Antwort auf Beitrag Nr.: 36.541.046 von hadesitem am 09.02.09 14:19:17

wäre toll wenn es hier auch mal demnächst so abgeht wie bei Weststar heute

[hadesitem]

Antwort auf Beitrag Nr.: 36.541.128 von Bignugget am 09.02.09 14:28:39

da bin ich mit einer kleinen posi drin aber hier sollte es genauso laufen dann isses schön
irgendwie verspreche ich mir hier ne menge ich weiß nicht warum......nachher sind wir wieder schlauer

[jarek_1]

hi all noch 28 min dann geht es los

[Gandyx]

Dann schauen wir mal was der Tag so bringt.

[hadesitem]

ist endlich bewegung drin...........wer wagt mal ein sk für heute??

[Pokerlui007]

für uns wären 0,015€ super für heute!!

[hadesitem]

Antwort auf Beitrag Nr.: 36.541.565 von Pokerlui007 am 09.02.09 15:16:18

wäre ok ich glaube an 0.016 und etwas mehr.....euphorie verlass mich nie

[jarek_1]

[Gandyx]

Antwort auf Beitrag Nr.: 36.541.556 von hadesitem am 09.02.09 15:15:20

ich tippe mal auf 0,02

[Pokerlui007]

wow unser ask ist eben von 0,013 auf 0,015 gestiegen...hoffe es bleibt jetzt da oder geht noch mehr hoch...

[jarek_1]

Cord Blood America Now Part of New ETF Innovators Stem Cell Index

SANTA MONICA, CA, Feb 09, 2009 (MARKET WIRE via COMTEX) -- Cord Blood America, Inc. (OTCBB: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that the Company is now listed on the ETF Innovators Emerging Stem Cell Index of U.S.-listed stocks. For more information, see the social media news room at http://www.intelligendo.com.

ETF Innovators, known for creating new global equity indexes with a focus in the healthcare industry, will track the total market value and stock price changes as an indicator of investor and trader sentiment toward the stem cell and regenerative medicine space.

"We are pleased by this recognition. Two thousand and nine has been, so far, both very interesting and positive for stem cell companies, and we're pleased to see this impressive index following our sector," said Matthew Schissler, Founder and CEO of Cord Blood America.

About Cord Blood America

Cord Blood America (OTCBB: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTCBB: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.

SOURCE: Cord Blood America, Inc.

Copyright 2009 Market Wire, All rights reserved.

-0-

SUBJECT CODE: Medical and Healthcare:Alternative
Medical and Healthcare:Facilities and Providers
Medical and Healthcare:Surgery and Treatments

[jarek_1]

[hadesitem]

ist wieder mein englisch zu schlecht........muß mal übersetzen mit google

[Gandyx]

Sind wieder viele starke Käufe hier heute.

[Bignugget]

Cord Blood America Now Part of New ETF Innovators Stem Cell Index
Monday February 9, 2009, 9:35 am EST
Yahoo! Buzz Print Related:Cord Blood America Inc.
SANTA MONICA, CA--(MARKET WIRE)--Feb 9, 2009 -- Cord Blood America, Inc. (OTC BB:CBAI.OB - News), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that the Company is now listed on the ETF Innovators Emerging Stem Cell Index of U.S.-listed stocks. For more information, see the social media news room at http://www.intelligendo.com.
Related Quotes
Symbol Price Change
CBAI.OB 0.0146 0.0000


{"s" : "cbai.ob","k" : "c10,l10,p20,t10","o" : "","j" : ""} ETF Innovators, known for creating new global equity indexes with a focus in the healthcare industry, will track the total market value and stock price changes as an indicator of investor and trader sentiment toward the stem cell and regenerative medicine space.



"We are pleased by this recognition. Two thousand and nine has been, so far, both very interesting and positive for stem cell companies, and we're pleased to see this impressive index following our sector," said Matthew Schissler, Founder and CEO of Cord Blood America.About Cord Blood America

Cord Blood America (OTC BB:CBAI.OB - News) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC BB:CBAI.OB - News), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.

Contact:

[jarek_1]

Antwort auf Beitrag Nr.: 36.541.877 von Bignugget am 09.02.09 15:46:16

hört sich gut an muss leider weg bin in einer std. wieder da.

[sorby]

New Emerging Stem Cell Index


Shares of Geron (GERN) and other well known stem cell and regenerative medicine stocks such as Osiris Therapeutics (OSIR) and StemCells (STEM) have been soaring since the FDA allowed human clinical testing for Geron's embryonic stem cell treatment candidate for spinal cord injuries.

The accompanying table (click to enlarge) highlights 25 U.S.-listed stem cell and regenerative medicine companies with market caps of below $200M which are included in the ETF Innovators Emerging Stem Cell Index. The companies are also listed below in descending order by market cap.

BioMimetic Therapeutics (BMTI)
Cytori Therapeutics (CYTX)
RTI Biologics (RTIX)
Aastrom Biosciences (ASTM)
Mesoblast (MBLTY)
Neuralstem (CUR)
Osteotech (OSTE)
ThermoGenesis (KOOL)
RegeneRx Biopharma (RGN)
Advanced Cell Tecchology (ACTC)
Pluristem Therapeutics (PSTI)
Athersys (ATHX)
International Stem Cell Corp (ISCO)
Stem Cell Innovations (SCLL)
Bioheart (BHRT)
CellCyte Genetics Corp (CCYG)
Stem Cell Therapeutics (SCTPF)
Brainstorm Cell Therapeutics (BCLI)
Opexa Therapeutics (OPXA)
Stem Cell Authority (SCAL)
Neostem (NBS)
Stem Cell Therapy Internt'l (SCII)
Cord Blood America (CBAI)
MultiCell Technologies (MCET)
LifeStem International (LSTM)

While regenerative medicine holds enormous potential for breakthrough medical treatments, investors and traders should be cautious as the entire space is an extreme momentum trade since the FDA news to allow human testing of embryonic stem cells. President Obama is also expected to lift the federal ban under the previous administration to allow federal funding of stem cell research, providing another boon to these companies.

[Bignugget]

Antwort auf Beitrag Nr.: 36.541.926 von jarek_1 am 09.02.09 15:50:37

muss leider nachher auch weg und komme spät wieder rein


aber sieht gut aus finde ich

jeden Tag 10-20 %

weitere positive News

immer mehr werden auf CBAI aufmerksam

[Bignugget]

Antwort auf Beitrag Nr.: 36.541.926 von jarek_1 am 09.02.09 15:50:37

der große Durchbruch sollte erst ab 0.025 kommen

Lass die Amis erstmal die News verdauen

[Gandyx]

Antwort auf Beitrag Nr.: 36.542.141 von Bignugget am 09.02.09 16:13:29

Im moment wird erst mal um die 0,016 gekämpft. Bin gespannt wann die fällt...

[Bignugget]

Antwort auf Beitrag Nr.: 36.542.167 von Gandyx am 09.02.09 16:16:58

unwichtig haptsache die Richtung stimmt

und die hat der CEO ganz klar für 2009 vorgegeben

"We are pleased by this recognition. Two thousand and nine has been, so far, both very interesting and positive for stem cell companies, and we're pleased to see this impressive index following our sector," said Matthew Schissler, Founder and CEO of Cord Blood America.About Cord Blood America

[hadesitem]

Antwort auf Beitrag Nr.: 36.542.167 von Gandyx am 09.02.09 16:16:58

und durch.......

[Gandyx]

Antwort auf Beitrag Nr.: 36.542.221 von Bignugget am 09.02.09 16:21:34

Stimmt, und wie es aussieht geht es jetzt auch los. Kurs ist schön am steigen..

[Bignugget]

Antwort auf Beitrag Nr.: 36.542.259 von hadesitem am 09.02.09 16:25:31

[imghttp://de.advfn.com/p.php?pid=staticchart&s=NO^CBAI&p=0&t=15&dm=0&vol=1][/img]

[Gandyx]

Antwort auf Beitrag Nr.: 36.542.259 von hadesitem am 09.02.09 16:25:31

der erste Schritt in die richtige richtung.

[Bignugget]

Antwort auf Beitrag Nr.: 36.542.314 von Gandyx am 09.02.09 16:29:24

[Bignugget]

Antwort auf Beitrag Nr.: 36.542.314 von Gandyx am 09.02.09 16:29:24

muss weg!!

bis späetr und viel Spass

[hadesitem]

ich mache jetzt feierabend, ich muß zu hause erst mal die news übersetzen.......

[jarek_1]

so bin wieder da und muss sagen das sieht Weltklasse aus

[Gandyx]

so, die 0,017 haben wir also schon angekratzt.

[jarek_1]

Stockwire.com: Cord Blood America, Inc. (OTCBB: CBAI) just released some important news.

Feb 09, 2009 (M2 PRESSWIRE via COMTEX) -- Cord Blood America, Inc. (OTCBB: CBAI), just announced Cord Blood America Now Part of New ETF Innovators Stem Cell Index.

A dedicated Chat Room for Cord Blood America, has been created at STOCKWIRE.com to discuss this news event.

Visit the following link to begin chatting with your fellow shareholders: http://www.stockwire.com/chat" target="_blank" rel="nofollow ugc noopener">http://www.stockwire.com/chat



About Stockwire:

Stockwire is one of the largest communities for Micro Cap Investors. We are the only place on the internet to provide LIVE CHAT ROOMS for dedicated stocks.

We have also pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.

The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.

Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.

As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.

While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the National Association of Securities Dealers ("NASD") at www.nasd.com. The NASD has published information on how to invest carefully at its web site.

Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml

Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.

From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.

Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com. To the degrees enumerated herein, this newsletter and website should not be regarded as an independent publication.

The editor, members of the editor's family, and/or entities with which the editor is affiliated aside from Stockwire Research Group Inc. (SRGI) itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE.COM.

We often accept restricted shares of company stock; by SEC regulations, restricted shares cannot be sold into the market for a period of at least one year from the time that the shares are issued. In such cases, we detail in the Disclaimer the specific term of any restrictions. We also receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. In such circumstances, we specify on our Disclaimer the terms of the options received. On occasion, we also accept free-trading shares in a company that we cover. However, by policy we generally do not buy or sell any shares of a company's stock within three trading days after any such company's profile, commentary, or other company-specific information is disseminated on Stockwire.com Web site. In cases where we do trade within the three day window, our volume will never represent more than 5% of the daily volume, thereby minimizing any effect we could have on the potential price movement.

While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm." target="_blank" rel="nofollow ugc noopener">http://www.stockwire.com/disclaimer_profiles.htm.

CONTACT: The Stockwire Group Tel: [phone] e-mail: [e-mail] WWW: http://www.stockwire.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [e-mail].

(C)1994-2009 M2 COMMUNICATIONS LTD

[jarek_1]

http://www.pinksheets.com/pink/quote/quote.jsp?symbol=CBAI#g…

[jarek_1]

[gerdass]

Antwort auf Beitrag Nr.: 36.543.003 von jarek_1 am 09.02.09 17:36:06

http://www.pinksheets.com/pink/quote/quote.jsp?symbol=CBAI#g…" target="_blank" rel="nofollow ugc noopener">
http://www.pinksheets.com/pink/quote/quote.jsp?symbol=CBAI#g…

[gerdass]

Antwort auf Beitrag Nr.: 36.542.569 von jarek_1 am 09.02.09 16:54:06

Weltklasse kommt erst noch

[gerdass]

I think CBAI is a rocket ready to blast off. We have held very nicely! To much happening with stems and this company!

[gerdass]

http://quote.barchart.com/texpert.asp?sym=cbai&code=BSTK

[Gandyx]

So, der Kurs zieht schon wieder an. Ich denke wir können heute alle ziemlich zufrieden sein.

[gerdass]

Antwort auf Beitrag Nr.: 36.543.663 von Gandyx am 09.02.09 18:47:34

das sieht sehr gut aus

[Gandyx]

Antwort auf Beitrag Nr.: 36.543.704 von gerdass am 09.02.09 18:52:31

jepp, leichte gewinnmitnahmen und jetzt weiter up.

[gerdass]

Antwort auf Beitrag Nr.: 36.543.718 von Gandyx am 09.02.09 18:55:06

Gewinne nehme ich hier noch lange nicht mit
wir stehen am Anfang

[gerdass]

[Gandyx]

Antwort auf Beitrag Nr.: 36.543.739 von gerdass am 09.02.09 18:57:43

ich bei diesen Aussichten auch nicht.

[gerdass]

Antwort auf Beitrag Nr.: 36.543.718 von Gandyx am 09.02.09 18:55:06

Ich kötte das Potenzial dieser Aktie nich einschätzen
es muß gewaltig sein

[Gandyx]

wow, und nochmal 1,75 millionen aus dem ask gekauft. und mit 100 tausend den kurs wieder auf 0,0165 gedrückt. ein schelm der böses dabei denkt.

[sneake]

Antwort auf Beitrag Nr.: 36.543.792 von Gandyx am 09.02.09 19:03:49

vieleicht wird diluted?

[Tom06]

absolute Frechheit: In Berlin geben Sie Dir gerade 0,011 für die Aktien der CBAI!!

Ich möchte zwar noch nicht verkaufen, aber das ist doch die Oberfrechheit......zumal ich über meinen Anbieter nur in Berlin Ver-/Kaufen kann

Wann werden andere Handelsplätze aufspringen, so dass der Wettbewerb die Preise fairer handelt?

Kann man irgendwo den Vorschlag machen?

[Gandyx]

Antwort auf Beitrag Nr.: 36.543.837 von Tom06 am 09.02.09 19:10:20

Ich denke um so mehr das Interesse steigt, umso mehr handel und umso Fairere preise...
und dann Springen die anderen Börsen erst auf.

[Tom06]

Antwort auf Beitrag Nr.: 36.543.854 von Gandyx am 09.02.09 19:12:51

Soll ich die Handelsplätze anschreiben ???

[Gandyx]

Antwort auf Beitrag Nr.: 36.543.887 von Tom06 am 09.02.09 19:17:44

kannst sie ja mal darauf aufmerksam machen. Vielleicht haben sie noch nicht gemerkt, das hier was geht.

[gerdass]

[Bignugget]

Antwort auf Beitrag Nr.: 36.544.035 von gerdass am 09.02.09 19:34:10

taucht in immer mehr News-Foren auf

es hat noch nicht richtig begonnen oder



Feb 9, 2009 OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday Report for Monday, February 9th SPNG, BANI, DVAX, SPCB, RF, CBAI

Feb 9, 2009 PennyPerformers.com: "Penny Stocks that Perform" picks are: AWEC, BSRC, CBAI, NNVC, UNCO

Feb 9, 2009 StandoutStocks.com: "Stocks that Standout" features today: AWEC, BWIH, CBAI, CWSI, SSLR

Feb 9, 2009 Stockwire.com: Cord Blood America, Inc. (OTCBB: CBAI) just released some important news.

Feb 9, 2009 Cord Blood America Now Part of New ETF Innovators Stem Cell Index

[Bignugget]

Antwort auf Beitrag Nr.: 36.544.035 von gerdass am 09.02.09 19:34:10

wenn sie nicht stark dilutieren

sollten bald die alten höhen wieder möglich sein imo

[gerdass]

Antwort auf Beitrag Nr.: 36.544.175 von Bignugget am 09.02.09 19:48:39

Gut möglich, dass wir heute schon die 2 Cent-Marke durchlaufen.

[Bignugget]

Antwort auf Beitrag Nr.: 36.544.266 von gerdass am 09.02.09 20:01:07

das glaube ich nicht

lieber langsam aber sicher nach oben

[Bignugget]

Antwort auf Beitrag Nr.: 36.544.266 von gerdass am 09.02.09 20:01:07

hätte aber nichts dagegen

[Bignugget]

Antwort auf Beitrag Nr.: 36.544.266 von gerdass am 09.02.09 20:01:07

in ihub sind wir unter den Top 9

Volumen Top 2


Symbols Name Price $Chg %Chg Volume
GNTA Genta 0.0150 0.0028 22.95 82,370,250
CBAI Cord Blood America 0.0166 0.0020 13.70 48,542,621
GGLB Green Globe Intl 0.0002 0.0001 100.00 41,586,050
CMLT Camelot Entertainmnt 0.0001 0.0000 0.00 27,927,999
RMTD Remote Dynamics 0.0001 0.0000 0.00 26,369,400
GSPG Goldspring 0.0160 0.0002 1.27 26,002,504
UVSE Universal Energy Cp 0.0001 0.0000 0.00 25,204,992
MOBL Mobilepro Corp 0.0006 0.0001 20.00 18,553,817
JNIP Juniper Grp 0.0005 -0.0001 -16.67 13,597,933
SPNG Spongetech Delivery 0.0150 -0.0003 -1.96 12,373,714
HBSC Human Biosystems 0.0018 -0.0012 -40.00 11,624,827

[gerdass]

Antwort auf Beitrag Nr.: 36.544.331 von Bignugget am 09.02.09 20:08:28

Das kann vorteilhaft sein.

[jarek_1]

hi jungs, sehe es auch so, langsam hoch und dann Explosion

denke wir werde heute noch die 0,017 testen , habe da ein gutes Gefühl dabei und gehen vielleicht durch.

nur meine Meinung

muss schon wieder weg bis dann

[Vaterland]

CORD BLOOD AMERICA INC. REGISTERED SHARES DL -,0001 (A0EAGC) Kurs vom 09.02. | 21:48 0,0168 USD
+0,00 | +15,07%
Nasdaq OTC Bulletin Board Berlin Bid 0,0167
5.000
Ask 0,0169
n.a.

US21839P1075 | Aktie
n.a. | USA

Details
Eröffnung 0,0166
Höchstkurs 0,017
Tiefstkurs 0,0155
Vortag 0,0146
Umsatz (in Stück) 60.076.630
Umsatz (in USD) n.a.
Preisfeststellungen 899
letzte Umsätze
21:48:45 5.000 0,0168
21:46:44 400.000 0,0168
21:46:44 400.000 0,0168
21:46:31 5.000 0,0167
21:46:31 5.000 0,0167
21:46:24 136.500 0,0167
21:46:24 94.401 0,0167

[Gustl24]

war ja ganz o.k. heute, hoffentlich morgen 2 cent -
in euroland oder nur in usa???
kommt leute gebt den ihub jungs mal ne saubere vorlage
in berlin

[gerdass]

Antwort auf Beitrag Nr.: 36.545.233 von Gustl24 am 09.02.09 22:06:48

wer kauft in Berlin

[jarek_1]

hi all bin wieder da, morgen frei bin sehr zufrieden heute und nochmal danke dir Bignugget für denn tipp

Freu mich schon auf morgen und will jetzt noch was zu CBAI suchen.-

[hadesitem]

Antwort auf Beitrag Nr.: 36.545.250 von gerdass am 09.02.09 22:08:18

guten morgen, ich kaufe in berlin ist aber nicht ratsam da der kurs immer verzerrt ist.........ich denke aber das könnte sich ändern wenn die aktie bekannt geworden ist!ich will auch noch mal nachlegen ich werde aber wahrscheinlich im amiland kaufen, hier ist eben kein handel....ätzend........aber ansonsten hat diese aktie bestimmt ein großes potential 0.10 cent sind in 2-3 monaten bestimmt drin...... mal sehen wie es weiter geht

[gerdass]

Antwort auf Beitrag Nr.: 36.545.959 von hadesitem am 10.02.09 07:43:30

Das hat was mit Angebot u. Nachfrage zu tun.Ist ja zu verstehen, dass jemand viel für seine Aktien in Berlin haben möchte u. umgekehrt jemand seine günstig kaufen möchte. Darum nie ohne Lim. in Berlin. Besser ist nur drüben kaufen.

[hadesitem]

was ist los.....keiner da, auch kein handel in D......ich hab mal eine spekulative frage ? wenn sich hier alles positiv entwickelt wie hoch könnte das teil mal schießen....? ich weiß das man das nie sagen kann, aber einfach mal flash for fantasie.....

[Bignugget]

Antwort auf Beitrag Nr.: 36.547.336 von hadesitem am 10.02.09 11:06:25

ich halte nichts von solchen Prognosen da es immerwieder irgendwelche Vollpfosten gibt, die einem dafür zur Rechenschaft ziehen

deshalb look at these= guckst Du hier

Bild Dir Deine Meinung

[koronis]

ich sehe 0,2 vorerst als Kursziel, wenn sich alles positiv entwickelt. (aber das ist meine persönliche Meinung)

[gerdass]

Antwort auf Beitrag Nr.: 36.547.456 von Bignugget am 10.02.09 11:17:58

Nur Geduld

[Gustl24]

es gibt noch stücke zum schnäppchenpreis
von .015 E in berlin - los wegkaufen

[hadesitem]

ok das sind mal paar hausnummern......aber an 0.2 sind erst mal realistisch oder (be)greifbar........sollten hier mal wieder kurse in richtung 1$ laufen kann man richtig reich werden.......
auf alle fälle bedanke ich mich für die empfehlung, ich weiss gar nicht mehr wer es war, aber es war im qi thread.........danke und wenn es klappt und ich reich bin lade ich mal zum urlaub ein aber den kann dann jeder selber zahlen

[gerdass]

Antwort auf Beitrag Nr.: 36.547.519 von Gustl24 am 10.02.09 11:26:22

Mag sein, dass sie heute noch weggehen

[gerdass]

http://investorshub.advfn.com/boards/read_msg.aspx?message_i…

[hadesitem]

Antwort auf Beitrag Nr.: 36.547.680 von gerdass am 10.02.09 11:46:47

wenn ich richtig übersezt habe kann man das teil bis 0.3-0.5 traden.......also ca 0.25-0.4 € und alle lächeln im frühling........ ich könnte es gebrauchen

[Bignugget]

Antwort auf Beitrag Nr.: 36.547.853 von hadesitem am 10.02.09 12:04:59

die Stimmung ist drüben durchweg positiv

wir werden noch viel Spass haben mit CBAI

die Haupttriebwerke haben noch nicht gezündet

[gerdass]

Antwort auf Beitrag Nr.: 36.547.853 von hadesitem am 10.02.09 12:04:59

Wenn nichts dazwischen kommt, werde ich alle Aktien aus 2008 halten, da steuerfrei

[hadesitem]

Antwort auf Beitrag Nr.: 36.548.134 von gerdass am 10.02.09 12:41:02

na da hast du welche für 0.00....bekommen oh mann eh da wirst du reich!!! na ich sehe zu das ich mir 1 mio min ins depot packe und dann passt es auch für mich

[Bignugget]

Antwort auf Beitrag Nr.: 36.548.254 von hadesitem am 10.02.09 12:57:22

OTC Select Announces Morning Daily Stock Watch

New York, NY, Feb 10, 2009 (WORLD STOCK WIRE via COMTEX) -- OTC Select tracks stocks daily and is pleased to offer its stock alerts. Investors can receive FREE Stock Alerts by visiting OTC Select at the following: http://www.otcselect.com.
Today's early morning alerts include: Banneker, Inc. (OTC: BANI), Cord Blood America, Inc. (OTCBB: CBAI), Genta Incorporated (OTCBB: GNTA), GoldSpring, Inc. (OTCBB: GSPG) and Minera Andes Inc. (OTCBB: MNEAF).
About Banneker

Banneker, Inc, is a manufacturer and distributor of quality watches and fine jewelry based on the legend of Benjamin Banneker. Esteem Enterprises, a wholly owned subsidiary of Banneker, Inc, teamed with Jostens, Inc. and created the first ever urban line of graduation jewelry and class rings.

About Cord Blood America

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. visit: www.corcell.com.
About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its DNA/RNA Medicines program. Genta is currently recruiting patients to the AGENDA Trial, a global Phase 3 trial of Genasense in patients with advanced melanoma. The leading drug in Genta's Small Molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. The Company has developed G4544, an oral formulation of the active ingredient in Ganite, that has recently entered clinical trials as a potential treatment for diseases associated with accelerated bone loss. The Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same class of drugs as paclitaxel and docetaxel. Ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, visit: www.genta.com.

About GoldSpring, Inc.

GoldSpring, Inc. is a North American precious metals mining company, focused in Nevada, with extensive, contiguous property in the Comstock Lode District. The company was formed in mid-2003, and has acquired properties in the Comstock Lode. The Company's objectives are to increase reserves through exploration, expand its footprint in the Comstock, resume mining, optimize its production, and maximize shareholder value.

About Minera Andes

Minera Andes is a gold, silver and copper exploration company working in Argentina. The Corporation holds approximately 304,000 acres of mineral exploration land in Argentina. Minera Andes holds a 49% interst in the San Jose Project, an operating gold and silver mine. Minera Andes is also exploring the Los Azules copper project in San Juan province, where an exploration program has defined a resource and a preliminary assessment has been completed. The Corporation presently has 190,158,851 shares issued and outstanding.

ABOUT OTC Select

OTC Select (www.otcselect.com) is a stock watch website that provides free daily alerts on stocks. OTC Select's alerts include news releases or daily e-mails on stocks in all sectors of the market. These include stocks with high or low volume, penny stocks, stocks with technical indicators and much more. OTC Select also tracks stocks that may be moving upwards or downwards. OTC Select also features companies on its website with research reports, analysis, and newsletters.

OTC Select is an independent electronic publication that provides information on selected publicly traded companies. OTC Select is not a registered investment advisor or broker-dealer. OTC Select including affiliates, officers, directors, contractors and employees may buy, sell or hold shares in any company mentioned herein and may profit in the event those shares increase or decrease in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.

To join and start receiving our FREE e-mail alerts, please visit: http://www.otcselect.com/subscribe.html

Disclaimers-

Release of Liability: Through use of this website viewing or using you agree to hold OTCSelect.com, its operators, owners, and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities.

The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTC Select encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTC Select makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. OTC Select has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor's sole risk. OTC Select also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in any stock (large-cap, small-cap, or micro-cap security) is highly speculative and carries an extremely high degree of risk. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. OTC Select makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through OTCSelect.com. OTC Select owners may or may not hold positions in any of the companies that are profiled.

SAFE HARBOR: The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. These statements are not guarantees of future performance and involve significant risks and uncertainties. Actual results may vary materially from those in the forward-looking statements. Factors that could cause actual results to differ include but are not limited to; the size and growth of the market for the company's products, the company's ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, the effectiveness of management's strategies and decisions, general economic and business conditions, new or modified statutory or regulatory requirements and changing price and market conditions. Investing in securities is speculative and carries risk. Past performance does not guarantee future results. No assurance can be given that these are all the factors that could cause actual results to vary materially from the forward-looking statements. The following report is neither an offer to buy or sell securities. Never invest in any stock featured on the OTC Select Stock Watch website unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site, or joining our email list.

.

OTC Select

Alerts

www.otcselect.com

New York, NY -

USA

Phone: [e-mail]

Source: Alerts

Note: The following press release was submitted by: Alerts, and World Stock Wire, Inc. is not liable for the contents of this press release.




(C) 2009 World Stock Wire, Inc. All rights reserved.
-0-

[Bignugget]

Antwort auf Beitrag Nr.: 36.548.134 von gerdass am 10.02.09 12:41:02

Hi Gerda

kannst du damit etwas anfangen? Was bedeutet das?

Filing vom 10.02.2009

http://pinksheets.com/edgar/GetFilingHtml?FilingID=6392580

[Pokerlui007]

Antwort auf Beitrag Nr.: 36.548.406 von Bignugget am 10.02.09 13:14:40

dass der kurs heute durch die decke geht!!

[hadesitem]

immer wieder news, wer mir einen gefallen tu will der setzt paar stichpunkte auf deutsch rein ich muß immer erst mit translater übersetzen....

[Bignugget]

und hier wieder News

Obama guarantees reversal of Bush's pro-life stem cell policy
By Tom Strode / Baptist Press
Monday, February 09, 2009


http://townhall.com/news/religion/2009/02/09/obama_guarantee…

WASHINGTON (BP)--President Obama has promised Democratic lawmakers he will issue an executive order reversing President Bush's ban on federal funds for stem cell research that destroys human embryos.

"I guarantee you that we will sign an executive order for stem cells," the president told Democrats in the House of Representatives attending a retreat Feb. 5 in Williamsburg, Va. The Washington Times reported Obama's comments, citing three sources in the closed-door meeting who asked to remain anonymous.

While Obama's support for government funding of embryonic stem cell research (ESCR) is well known, a question had developed since his Jan. 20 inauguration about whether he would actually use an executive order. There seemed to be some indication he might decline that method of rescinding the Bush policy and allow Congress to deal with the issue.

At the Democratic retreat, Obama endorsed congressional action as well, telling the representatives a legislative measure is needed to prevent a future president from reversing the policy again, according to The Times. Obama said he would coordinate the timing of his order's release with Congress.

"President Obama's promise is extremely disappointing but not surprising," said Richard Land, president of the Southern Baptist Ethics & Religious Liberty Commission. "Once again, as in the case of overturning the Mexico City Policy, President Obama's action forces Americans who find such research both barbaric and repugnant to subsidize it with their tax money.

"Reduced to its basics, killing the tiniest human beings in their embryonic stage of development for the possible medical benefits of older and more developed human beings is quite simply high-tech cannibalism in which we devour our own young for the sole purpose of treating other human beings who are merely fortunate enough to be older and able to defend themselves in a way the tiniest human beings are not," Land told Baptist Press.

Stem cells are the body's master cells that can develop into other cells and tissues, providing hope for the development of cures for a variety of diseases and other ailments.

Bush issued an executive order in August 2001 barring the use of federal funds in stem cell research that results in the destruction of human embryos. Extracting stem cells from an embryo destroys the donor.

Congress twice approved legislation to overturn Bush's policy, but the president vetoed both bills. Efforts to override the vetoes failed.

The ESCR funding ban is undergirded by a 1996 federal law that prohibits federal funds from being used for the creation of human embryos for research, as well as experimentation that destroys or threatens the health or life of embryos. That measure, known as the Dickey Amendment, has been subject to various interpretations, said Douglas Johnson, legislative director of the National Right to Life Committee. A legal challenge could ensue if Obama rescinds the ESCR funding ban, with supporters of the Bush policy arguing in court the Obama order violates the Dickey Amendment, Johnson said.

The Dickey Amendment is part of the annual spending bill for the Department of Health and Human Services, so Congress has to approve it each year for it to remain in effect. The measure is named after its sponsor, former Republican Rep. Jay Dickey of Arkansas. Not only is ESCR lethal for the non-voluntary donor, but embryonic stem cells have yet to provide treatments for any diseases in human beings. They also have been plagued by the development of tumors in lab animals.

Unlike research using embryos, extracting stem cells from non-embryonic sources -- such as umbilical cord blood, placentas, fat and bone marrow -- does not harm donors and has nearly universal support. Such research has produced treatments for at least 73 human ailments, according to Do No Harm, a coalition promoting ethics in research.

In the last 15 months especially, scientists have discovered ways of converting non-embryonic stem cells into cells that have nearly the identical properties of embryonic ones.

On Jan. 23, Obama issued an executive order overturning the Mexico City Policy, which prohibits international family planning organizations from receiving federal funds unless they agree not to perform or counsel for abortion, or lobby in order to liberalize the pro-life policies of foreign governments.

President Reagan originally established the Mexico City Policy in 1984, when it was announced at a conference in Mexico City. The policy remained in force until 1993, when President Clinton rescinded it on his second full day in the White House. President Bush reinstated it exactly eight years later.

Tom Strode is Baptist Press Washington bureau chief.

Copyright (c) 2009 Southern Baptist Convention, Baptist Press www.BPNews.net

[MC_DANIEL]

Posted by: Herb1 Date: Tuesday, February 10, 2009 8:40:09 AM
In reply to: cjstocksup who wrote msg# 3291 Post # of 3317

CJ, I tried to answer you yesterday but for technical reasons I was not able to post again. I did a lot of research over the weekend and am even more enthusiastic at our little gem CBAI. Trading is getting more and more regular and we are about to see the beginning of a real monster run . IMO.

Kind regards.

Herbert1

[Gustl24]

WER bitte hat zu diesem kurs in berlin verkauft und warum?

[Bignugget]

Antwort auf Beitrag Nr.: 36.549.205 von MC_DANIEL am 10.02.09 14:48:36

das denke ich auch so


die 0.011 täuscht in Berlin

da hat wohl jemand versucht bestens zu verkaufen und hat 11 bekommen


Ask wieder bei 15


Kurs wird ehe drüben gemacht

mal schauen wo die Reise heute hinführt

[MC_DANIEL]

Antwort auf Beitrag Nr.: 36.549.366 von Bignugget am 10.02.09 15:04:52

das gibts ja schöne Wunschvorstellungen . Mal schaun..

Posted by: cjstocksup Date: Tuesday, February 10, 2009 9:02:20 AM
In reply to: GeorgeTheStub who wrote msg# 3311 Post # of 3322
I agree 100% and I also do not mind adding at higher prices on the way up also. I firmly believe we will see .03 to .05 very fast, .10 in the next couple of weeks. If we get super volume again like we had almost 2 weeks ago we should hit .10 a lot sooner. We are acting just like ACTC did before it ran to .25.

[Bignugget]

Antwort auf Beitrag Nr.: 36.549.396 von MC_DANIEL am 10.02.09 15:07:29

ask 17

[MC_DANIEL]

[Gandyx]

So, dann wollen wir mal wieder.
Bin gespannt wo der Kurs heute hingeht...

[Gandyx]

Die 0,017 locker geknackt...

[MC_DANIEL]

[hadesitem]

dann fallen heute die 0.02

[Bignugget]

Antwort auf Beitrag Nr.: 36.549.659 von Gandyx am 10.02.09 15:32:49

anschnallen es geht wieder ziemlich steil hoch

[MC_DANIEL]

[Bignugget]

Antwort auf Beitrag Nr.: 36.549.669 von hadesitem am 10.02.09 15:33:53

sieht schwer danach aus

[mazuba]

sehr schön
wenn jarek das sieht ist er aus dem häuschen

[Bignugget]

Antwort auf Beitrag Nr.: 36.549.753 von mazuba am 10.02.09 15:40:54

er wird sich ein drittesmal bei mir bedanken





Posted by: PENNYSFROMHEAVEN Date: Tuesday, February 10, 2009 9:27:48 AM
In reply to: None Post # of 3335

GAP UP TO .02 AND A RUN AT .03 TODAY IMO